<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Internal Medicine Clinical Reference Guide</title>
    <style>
        * {
            box-sizing: border-box;
        }
        
        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Arial, sans-serif;
            font-size: 10pt;
            line-height: 1.4;
            margin: 0;
            padding: 0;
            color: #24292e;
            background: #f6f8fa;
        }
        
        .calculator {
            background: #fff3cd;
            border: 2px solid #ffc107;
            border-radius: 8px;
            padding: 15px;
            margin: 15px 0;
        }
        
        .calculator-title {
            font-weight: 600;
            color: #856404;
            font-size: 11pt;
            margin-bottom: 10px;
        }
        
        .calc-item {
            margin: 12px 0;
            padding: 8px;
            background: white;
            border-radius: 4px;
            border: 1px solid #e8e8e8;
        }
        
        .calc-item label {
            display: block;
            font-weight: 600;
            margin-bottom: 6px;
            color: #333;
            font-size: 9.5pt;
        }
        
        .calc-item .hint {
            display: block;
            font-size: 8pt;
            color: #666;
            font-weight: normal;
            margin-top: 2px;
            font-style: italic;
        }
        
        .calc-item select, .calc-item input[type="number"] {
            width: 100%;
            padding: 8px 10px;
            border: 2px solid #ddd;
            border-radius: 4px;
            font-size: 9.5pt;
            background: white;
            transition: border-color 0.2s;
        }
        
        .calc-item select:focus, .calc-item input[type="number"]:focus {
            outline: none;
            border-color: #0366d6;
            box-shadow: 0 0 0 3px rgba(3, 102, 214, 0.1);
        }
        
        .calc-item input[type="number"]::placeholder {
            color: #999;
            font-style: italic;
        }
        
        .calc-item input[type="checkbox"] {
            width: 18px;
            height: 18px;
            margin-right: 8px;
            cursor: pointer;
            vertical-align: middle;
        }
        
        .calc-item.checkbox-item {
            padding: 10px;
            cursor: pointer;
            transition: background 0.2s;
        }
        
        .calc-item.checkbox-item:hover {
            background: #f8f9fa;
        }
        
        .calc-item.checkbox-item label {
            cursor: pointer;
            margin: 0;
            display: inline;
            font-weight: 500;
        }
        
        .calc-result {
            background: #d4edda;
            border: 2px solid #28a745;
            padding: 12px;
            margin-top: 12px;
            border-radius: 6px;
            font-weight: 600;
        }
        
        .calc-result.high-risk {
            background: #f8d7da;
            border-color: #dc3545;
        }
        
        .calc-button {
            background: #0366d6;
            color: white;
            border: none;
            padding: 8px 16px;
            border-radius: 6px;
            cursor: pointer;
            font-size: 9pt;
            margin-top: 10px;
        }
        
        .calc-button:hover {
            background: #0256c7;
        }
        
        .calc-description {
            font-size: 9pt;
            color: #666;
            margin-top: 8px;
            padding: 8px;
            background: #f9f9f9;
            border-radius: 4px;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            background: white;
            box-shadow: 0 1px 3px rgba(0,0,0,0.12);
        }
        
        .nav-header {
            background: #24292e;
            color: white;
            padding: 20px 30px;
            position: sticky;
            top: 0;
            z-index: 100;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        
        .nav-header h1 {
            margin: 0;
            font-size: 22pt;
        }
        
        .nav-header p {
            margin: 5px 0 0 0;
            opacity: 0.9;
            font-size: 10pt;
        }
        
        .back-to-top {
            display: inline-block;
            background: #0366d6;
            color: white;
            padding: 8px 16px;
            text-decoration: none;
            border-radius: 6px;
            font-size: 9pt;
            margin-top: 10px;
            transition: background 0.2s;
        }
        
        .back-to-top:hover {
            background: #0256c7;
        }
        
        .toc {
            padding: 30px;
            background: #f6f8fa;
            border-bottom: 3px solid #e1e4e8;
            scroll-margin-top: 95px;
        }
        
        .toc h2 {
            margin-top: 0;
            color: #24292e;
            font-size: 18pt;
            border-bottom: 2px solid #e1e4e8;
            padding-bottom: 10px;
        }
        
        .toc-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(280px, 1fr));
            gap: 12px;
            margin-top: 20px;
        }
        
        .toc-item {
            background: white;
            border: 1px solid #e1e4e8;
            border-radius: 6px;
            padding: 12px;
            transition: all 0.2s;
        }
        
        .toc-item:hover {
            border-color: #0366d6;
            box-shadow: 0 2px 8px rgba(3,102,214,0.15);
            transform: translateY(-2px);
        }
        
        .toc-item a {
            text-decoration: none;
            color: #0366d6;
            font-weight: 600;
            font-size: 10pt;
            display: block;
        }
        
        .toc-item a:hover {
            text-decoration: underline;
        }
        
        .toc-number {
            color: #586069;
            font-size: 9pt;
            font-weight: normal;
        }
        
        .condition-page {
            padding: 0px 30px 30px 30px;
            border-bottom: 3px solid #e1e4e8;
            scroll-margin-top: 130px;
        }
        
        .page-header {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 20px 25px;
            margin: 0 -30px 25px -30px;
            border-radius: 0;
        }
        
        .page-header h2 {
            margin: 0;
            font-size: 20pt;
        }
        
        .page-header .subtitle {
            font-size: 10pt;
            margin-top: 5px;
            opacity: 0.95;
        }
        
        .section {
            margin-bottom: 18px;
        }
        
        .section-title {
            background: #0366d6;
            color: white;
            padding: 6px 12px;
            font-weight: 600;
            font-size: 11pt;
            margin-bottom: 8px;
            border-radius: 4px;
        }
        
        .section-content {
            padding-left: 12px;
        }
        
        .label {
            font-weight: 600;
            color: #24292e;
        }
        
        .two-column {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 15px;
            margin: 15px 0;
        }
        
        @media (max-width: 768px) {
            .two-column {
                grid-template-columns: 1fr;
            }
            .toc-grid {
                grid-template-columns: 1fr;
            }
        }
        
        .box {
            border: 2px solid #d73a49;
            background: #ffeef0;
            padding: 12px;
            border-radius: 6px;
        }
        
        .box-title {
            font-weight: 600;
            color: #d73a49;
            margin-bottom: 6px;
            font-size: 11pt;
        }
        
        .pearl-box {
            border: 2px solid #28a745;
            background: #dcffe4;
            padding: 12px;
            margin: 15px 0;
            border-radius: 6px;
        }
        
        .pearl-title {
            font-weight: 600;
            color: #28a745;
            margin-bottom: 6px;
            font-size: 11pt;
        }
        
        ul {
            margin: 6px 0;
            padding-left: 20px;
        }
        
        li {
            margin: 4px 0;
        }
        
        p {
            margin: 6px 0;
        }
        
        .footer-section {
            background: #24292e;
            color: white;
            padding: 30px;
            text-align: center;
        }
        
        .footer-section p {
            margin: 5px 0;
            opacity: 0.8;
        }
        
        @media print {
            .nav-header, .back-to-top {
                display: none;
            }
            .condition-page {
                page-break-after: always;
            }
            body {
                background: white;
            }
            .container {
                box-shadow: none;
            }
        }
        
        html {
            scroll-behavior: smooth;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="nav-header">
            <h1>Internal Medicine Clinical Reference Guide</h1>
            <p>40 Essential Conditions for Hospital Medicine</p>
            <a href="#toc" class="back-to-top">‚Üë Table of Contents</a>
        </div>
        
        <div id="toc" class="toc">
            <h2>üìã Table of Contents</h2>
            <div class="toc-grid">
                <div class="toc-item">
                    <a href="#acs"><span class="toc-number">1.</span> Acute Coronary Syndrome</a>
                </div>
                <div class="toc-item">
                    <a href="#heart-failure"><span class="toc-number">2.</span> Heart Failure Exacerbation</a>
                </div>
                <div class="toc-item">
                    <a href="#afib"><span class="toc-number">3.</span> Atrial Fibrillation</a>
                </div>
                <div class="toc-item">
                    <a href="#htn-emergency"><span class="toc-number">4.</span> Hypertensive Emergency</a>
                </div>
                <div class="toc-item">
                    <a href="#cap"><span class="toc-number">5.</span> Community-Acquired Pneumonia</a>
                </div>
                <div class="toc-item">
                    <a href="#copd"><span class="toc-number">6.</span> COPD Exacerbation</a>
                </div>
                <div class="toc-item">
                    <a href="#asthma"><span class="toc-number">7.</span> Asthma Exacerbation</a>
                </div>
                <div class="toc-item">
                    <a href="#pe"><span class="toc-number">8.</span> Pulmonary Embolism</a>
                </div>
                <div class="toc-item">
                    <a href="#sepsis"><span class="toc-number">9.</span> Sepsis/Septic Shock</a>
                </div>
                <div class="toc-item">
                    <a href="#aki"><span class="toc-number">10.</span> Acute Kidney Injury</a>
                </div>
                <div class="toc-item">
                    <a href="#hyperkalemia"><span class="toc-number">11.</span> Hyperkalemia</a>
                </div>
                <div class="toc-item">
                    <a href="#hyponatremia"><span class="toc-number">12.</span> Hyponatremia</a>
                </div>
                <div class="toc-item">
                    <a href="#dka"><span class="toc-number">13.</span> Diabetic Ketoacidosis</a>
                </div>
                <div class="toc-item">
                    <a href="#hhs"><span class="toc-number">14.</span> Hyperosmolar Hyperglycemic State</a>
                </div>
                <div class="toc-item">
                    <a href="#ugib"><span class="toc-number">15.</span> Upper GI Bleed</a>
                </div>
                <div class="toc-item">
                    <a href="#cirrhosis"><span class="toc-number">16.</span> Cirrhosis with Ascites</a>
                </div>
                <div class="toc-item">
                    <a href="#sbp"><span class="toc-number">17.</span> Spontaneous Bacterial Peritonitis</a>
                </div>
                <div class="toc-item">
                    <a href="#he"><span class="toc-number">18.</span> Hepatic Encephalopathy</a>
                </div>
                <div class="toc-item">
                    <a href="#pancreatitis"><span class="toc-number">19.</span> Acute Pancreatitis</a>
                </div>
                <div class="toc-item">
                    <a href="#cellulitis"><span class="toc-number">20.</span> Cellulitis</a>
                </div>
                <div class="toc-item">
                    <a href="#uti"><span class="toc-number">21.</span> Urinary Tract Infection</a>
                </div>
                <div class="toc-item">
                    <a href="#cdiff"><span class="toc-number">22.</span> C. difficile Infection</a>
                </div>
                <div class="toc-item">
                    <a href="#dvt"><span class="toc-number">23.</span> Deep Vein Thrombosis</a>
                </div>
                <div class="toc-item">
                    <a href="#stroke"><span class="toc-number">24.</span> Acute Ischemic Stroke</a>
                </div>
                <div class="toc-item">
                    <a href="#seizure"><span class="toc-number">25.</span> Seizure/Status Epilepticus</a>
                </div>
                <div class="toc-item">
                    <a href="#meningitis"><span class="toc-number">26.</span> Bacterial Meningitis</a>
                </div>
                <div class="toc-item">
                    <a href="#anemia"><span class="toc-number">27.</span> Anemia</a>
                </div>
                <div class="toc-item">
                    <a href="#neutropenic-fever"><span class="toc-number">28.</span> Neutropenic Fever</a>
                </div>
                <div class="toc-item">
                    <a href="#etoh-withdrawal"><span class="toc-number">29.</span> Alcohol Withdrawal</a>
                </div>
                <div class="toc-item">
                    <a href="#delirium"><span class="toc-number">30.</span> Delirium</a>
                </div>
                <div class="toc-item">
                    <a href="#hyperthyroid"><span class="toc-number">31.</span> Hyperthyroidism/Thyroid Storm</a>
                </div>
                <div class="toc-item">
                    <a href="#hypothyroid"><span class="toc-number">32.</span> Hypothyroidism/Myxedema Coma</a>
                </div>
                <div class="toc-item">
                    <a href="#adrenal"><span class="toc-number">33.</span> Adrenal Insufficiency</a>
                </div>
                <div class="toc-item">
                    <a href="#hypercalcemia"><span class="toc-number">34.</span> Hypercalcemia</a>
                </div>
                <div class="toc-item">
                    <a href="#hypomag"><span class="toc-number">35.</span> Hypomagnesemia</a>
                </div>
                <div class="toc-item">
                    <a href="#rhabdo"><span class="toc-number">36.</span> Rhabdomyolysis</a>
                </div>
                <div class="toc-item">
                    <a href="#transfusion"><span class="toc-number">37.</span> Transfusion Reactions</a>
                </div>
                <div class="toc-item">
                    <a href="#pleural-effusion"><span class="toc-number">38.</span> Pleural Effusion</a>
                </div>
                <div class="toc-item">
                    <a href="#pneumothorax"><span class="toc-number">39.</span> Pneumothorax</a>
                </div>
                <div class="toc-item">
                    <a href="#syncope"><span class="toc-number">40.</span> Syncope</a>
                </div>
                <div class="toc-item">
                    <a href="#pancreatitis"><span class="toc-number">19.</span> Acute Pancreatitis</a>
                </div>
                <div class="toc-item">
                    <a href="#cellulitis"><span class="toc-number">20.</span> Cellulitis</a>
                </div>
                <div class="toc-item">
                    <a href="#uti"><span class="toc-number">21.</span> Urinary Tract Infection</a>
                </div>
                <div class="toc-item">
                    <a href="#c-diff"><span class="toc-number">22.</span> C. difficile Infection</a>
                </div>
                <div class="toc-item">
                    <a href="#dvt"><span class="toc-number">23.</span> Deep Vein Thrombosis</a>
                </div>
                <div class="toc-item">
                    <a href="#stroke"><span class="toc-number">24.</span> Acute Ischemic Stroke</a>
                </div>
                <div class="toc-item">
                    <a href="#seizure"><span class="toc-number">25.</span> Seizure</a>
                </div>
                <div class="toc-item">
                    <a href="#meningitis"><span class="toc-number">26.</span> Bacterial Meningitis</a>
                </div>
                <div class="toc-item">
                    <a href="#anemia"><span class="toc-number">27.</span> Anemia</a>
                </div>
                <div class="toc-item">
                    <a href="#neutropenic-fever"><span class="toc-number">28.</span> Neutropenic Fever</a>
                </div>
                <div class="toc-item">
                    <a href="#alcohol-withdrawal"><span class="toc-number">29.</span> Alcohol Withdrawal</a>
                </div>
                <div class="toc-item">
                    <a href="#delirium"><span class="toc-number">30.</span> Delirium</a>
                </div>
                <div class="toc-item">
                    <a href="#hyperthyroid"><span class="toc-number">31.</span> Hyperthyroidism/Thyroid Storm</a>
                </div>
                <div class="toc-item">
                    <a href="#hypothyroid"><span class="toc-number">32.</span> Hypothyroidism/Myxedema Coma</a>
                </div>
                <div class="toc-item">
                    <a href="#adrenal-crisis"><span class="toc-number">33.</span> Adrenal Insufficiency/Crisis</a>
                </div>
                <div class="toc-item">
                    <a href="#hypercalcemia"><span class="toc-number">34.</span> Hypercalcemia</a>
                </div>
                <div class="toc-item">
                    <a href="#hypomag"><span class="toc-number">35.</span> Hypomagnesemia</a>
                </div>
                <div class="toc-item">
                    <a href="#rhabdo"><span class="toc-number">36.</span> Rhabdomyolysis</a>
                </div>
                <div class="toc-item">
                    <a href="#transfusion"><span class="toc-number">37.</span> Transfusion Reaction</a>
                </div>
                <div class="toc-item">
                    <a href="#effusion"><span class="toc-number">38.</span> Pleural Effusion</a>
                </div>
                <div class="toc-item">
                    <a href="#pneumothorax"><span class="toc-number">39.</span> Pneumothorax</a>
                </div>
                <div class="toc-item">
                    <a href="#syncope"><span class="toc-number">40.</span> Syncope</a>
                </div>
            </div>
        </div>

        <!-- PAGE 1: ACUTE CORONARY SYNDROME -->
        <div id="acs" class="condition-page">
            <div class="page-header">
                <h2>1. ACUTE CORONARY SYNDROME (ACS)</h2>
                <div class="subtitle">STEMI ‚Ä¢ NSTEMI ‚Ä¢ Unstable Angina</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Classic:</span> Substernal chest pain/pressure >20 minutes, radiation to jaw/left arm/back, diaphoresis, nausea, dyspnea. Pain not relieved by rest or nitroglycerin.</p>
                    <p><span class="label">Alternate Presentations:</span></p>
                    <ul>
                        <li><strong>Diabetics/Elderly/Women:</strong> Atypical symptoms - dyspnea alone, weakness, epigastric pain, syncope</li>
                        <li><strong>Silent MI:</strong> No chest pain (30% of diabetics)</li>
                        <li><strong>RV Infarction:</strong> Hypotension with clear lungs, JVD, Kussmaul sign</li>
                        <li><strong>Posterior MI:</strong> Isolated ST depression V1-V3, need posterior leads (V7-V9)</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">Immediate:</span> ECG within 10 minutes, troponin (repeat at 3 and 6 hours if initial negative), CBC, BMP, PT/INR, lipid panel, CXR</p>
                    <p><span class="label">STEMI Criteria:</span> ST elevation ‚â•1mm in 2+ contiguous leads OR new LBBB OR ST depression V1-V3 (posterior MI)</p>
                    <p><span class="label">Calculations:</span> <a href="#calc-heart" style="color: #0366d6;">HEART Score</a>, <a href="#calc-timi-stemi" style="color: #0366d6;">TIMI STEMI</a>, <a href="#calc-timi-nstemi" style="color: #0366d6;">TIMI NSTEMI</a>, <a href="#calc-grace" style="color: #0366d6;">GRACE Score</a></p>
                    
                    <!-- HEART Score Calculator -->
                    <div id="calc-heart" class="calculator">
                        <div class="calculator-title">üßÆ HEART Score Calculator</div>
                        <div class="calc-description">
                            <strong>Use:</strong> Risk stratification for chest pain patients to determine if safe for outpatient evaluation. Score 0-3 = low risk (outpatient), 4-6 = moderate risk (observe), 7-10 = high risk (admit).
                        </div>
                        
                        <div class="calc-item">
                            <label>History
                                <span class="hint">How suspicious is the patient's story for ACS?</span>
                            </label>
                            <select id="heart-history">
                                <option value="0">Slightly suspicious - probably not cardiac (0)</option>
                                <option value="1" selected>Moderately suspicious - could be cardiac (1)</option>
                                <option value="2">Highly suspicious - typical angina (2)</option>
                            </select>
                        </div>
                        
                        <div class="calc-item">
                            <label>ECG
                                <span class="hint">Initial ECG findings</span>
                            </label>
                            <select id="heart-ecg">
                                <option value="0" selected>Normal (0)</option>
                                <option value="1">Non-specific repolarization changes (1)</option>
                                <option value="2">Significant ST deviation (2)</option>
                            </select>
                        </div>
                        
                        <div class="calc-item">
                            <label>Age
                                <span class="hint">Patient's age in years</span>
                            </label>
                            <select id="heart-age">
                                <option value="0"><21 years (0)</option>
                                <option value="1">21-45 years (1)</option>
                                <option value="2" selected>45-65 years (2)</option>
                                <option value="2">>65 years (2)</option>
                            </select>
                        </div>
                        
                        <div class="calc-item">
                            <label>Risk Factors
                                <span class="hint">Count: HTN, DM, smoking, high cholesterol, family history, obesity</span>
                            </label>
                            <select id="heart-risk">
                                <option value="0">None (0)</option>
                                <option value="1" selected>1-2 risk factors (1)</option>
                                <option value="2">‚â•3 risk factors or history of atherosclerotic disease (2)</option>
                            </select>
                        </div>
                        
                        <div class="calc-item">
                            <label>Troponin
                                <span class="hint">Initial troponin level relative to upper limit of normal</span>
                            </label>
                            <select id="heart-trop">
                                <option value="0" selected>Normal - below upper limit (0)</option>
                                <option value="1">1-3√ó upper limit of normal (1)</option>
                                <option value="2">>3√ó upper limit of normal (2)</option>
                            </select>
                        </div>
                        
                        <button class="calc-button" onclick="calculateHEART()">Calculate HEART Score</button>
                        <div id="heart-result"></div>
                    </div>
                    
                    <!-- TIMI STEMI Calculator -->
                    <div id="calc-timi-stemi" class="calculator">
                        <div class="calculator-title">üßÆ TIMI Risk Score - STEMI</div>
                        <div class="calc-description">
                            <strong>Use:</strong> Predicts 30-day mortality in STEMI patients. Score 0-2 = 2% mortality, 3-4 = 5%, 5-6 = 12%, >6 = 36%.
                        </div>
                        
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-stemi-age65"> Age 65-74 years
                                <span class="hint">+2 points</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-stemi-age75"> Age ‚â•75 years
                                <span class="hint">+3 points</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-stemi-dm"> Diabetes, Hypertension, or Angina history
                                <span class="hint">+1 point</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-stemi-bp"> Systolic BP <100 mmHg
                                <span class="hint">+3 points</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-stemi-hr"> Heart rate >100 bpm
                                <span class="hint">+2 points</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-stemi-killip"> Killip class II-IV (rales, S3, pulmonary edema, shock)
                                <span class="hint">+2 points</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-stemi-weight"> Weight <67 kg (150 lbs)
                                <span class="hint">+1 point</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-stemi-anterior"> Anterior STEMI or LBBB
                                <span class="hint">+1 point</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-stemi-time"> Time to treatment >4 hours
                                <span class="hint">+1 point</span>
                            </label>
                        </div>
                        
                        <button class="calc-button" onclick="calculateTIMI_STEMI()">Calculate TIMI STEMI Score</button>
                        <div id="timi-stemi-result"></div>
                    </div>
                    
                    <!-- TIMI NSTEMI Calculator -->
                    <div id="calc-timi-nstemi" class="calculator">
                        <div class="calculator-title">üßÆ TIMI Risk Score - NSTEMI/UA</div>
                        <div class="calc-description">
                            <strong>Use:</strong> Risk of death, MI, or urgent revascularization within 14 days. Score 0-2 = 5% risk (low), 3-4 = 13% (moderate), 5-7 = 41% (high).
                        </div>
                        
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-nstemi-age"> Age ‚â•65 years
                                <span class="hint">+1 point</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-nstemi-risk"> ‚â•3 CAD risk factors
                                <span class="hint">HTN, DM, smoking, high cholesterol, family history (+1 point)</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-nstemi-cad"> Known CAD (stenosis ‚â•50%)
                                <span class="hint">Prior cath showing >50% stenosis (+1 point)</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-nstemi-asa"> Aspirin use in past 7 days
                                <span class="hint">+1 point</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-nstemi-angina"> Severe angina
                                <span class="hint">‚â•2 episodes within 24 hours (+1 point)</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-nstemi-ecg"> ST changes ‚â•0.5mm
                                <span class="hint">ST elevation or depression (+1 point)</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="timi-nstemi-trop"> Elevated cardiac markers
                                <span class="hint">Troponin or CK-MB elevated (+1 point)</span>
                            </label>
                        </div>
                        
                        <button class="calc-button" onclick="calculateTIMI_NSTEMI()">Calculate TIMI NSTEMI Score</button>
                        <div id="timi-nstemi-result"></div>
                    </div>
                    
                    <!-- GRACE Score Calculator -->
                    <div id="calc-grace" class="calculator">
                        <div class="calculator-title">üßÆ GRACE Score Calculator</div>
                        <div class="calc-description">
                            <strong>Use:</strong> Estimates in-hospital and 6-month mortality in ACS. Low risk <109, intermediate 109-140, high >140. More accurate than TIMI for mortality prediction.
                        </div>
                        
                        <div class="calc-item">
                            <label>Age (years)
                                <span class="hint">Patient's age - typical range 40-80</span>
                            </label>
                            <input type="number" id="grace-age" placeholder="e.g., 65" min="18" max="120" value="65">
                        </div>
                        
                        <div class="calc-item">
                            <label>Heart Rate (bpm)
                                <span class="hint">Beats per minute - typical range 60-100</span>
                            </label>
                            <input type="number" id="grace-hr" placeholder="e.g., 85" min="30" max="250" value="85">
                        </div>
                        
                        <div class="calc-item">
                            <label>Systolic Blood Pressure (mmHg)
                                <span class="hint">SBP at presentation - typical range 100-160</span>
                            </label>
                            <input type="number" id="grace-sbp" placeholder="e.g., 130" min="50" max="250" value="130">
                        </div>
                        
                        <div class="calc-item">
                            <label>Creatinine (mg/dL)
                                <span class="hint">Serum creatinine - normal 0.6-1.2 mg/dL</span>
                            </label>
                            <input type="number" id="grace-cr" placeholder="e.g., 1.0" step="0.1" min="0.1" max="15" value="1.0">
                        </div>
                        
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="grace-arrest"> Cardiac arrest at admission
                                <span class="hint">+39 points</span>
                            </label>
                        </div>
                        
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="grace-st"> ST segment deviation on ECG
                                <span class="hint">ST elevation or depression (+28 points)</span>
                            </label>
                        </div>
                        
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="grace-enzymes" checked> Elevated cardiac enzymes
                                <span class="hint">Troponin or CK-MB elevated (+14 points)</span>
                            </label>
                        </div>
                        
                        <div class="calc-item">
                            <label>Killip Class
                                <span class="hint">Clinical heart failure classification</span>
                            </label>
                            <select id="grace-killip">
                                <option value="0" selected>I - No heart failure signs (0)</option>
                                <option value="20">II - Rales or S3 gallop (+20)</option>
                                <option value="39">III - Pulmonary edema (+39)</option>
                                <option value="59">IV - Cardiogenic shock (+59)</option>
                            </select>
                        </div>
                        
                        <button class="calc-button" onclick="calculateGRACE()">Calculate GRACE Score</button>
                        <div id="grace-result"></div>
                    </div>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL</div>
                <div class="section-content">
                    <p><span class="label">Initial Management (MONA-BAH):</span></p>
                    <ul>
                        <li><strong>Morphine:</strong> 2-4mg IV PRN (use cautiously, may worsen outcomes)</li>
                        <li><strong>Oxygen:</strong> Only if SpO2 <90%</li>
                        <li><strong>Nitroglycerin:</strong> 0.4mg SL q5min √ó 3 (avoid if RV infarct, SBP <90, recent PDE5 inhibitor)</li>
                        <li><strong>Aspirin:</strong> 325mg PO chewed immediately</li>
                        <li><strong>Œ≤-Blocker:</strong> Metoprolol 25-50mg PO (avoid if HF, bradycardia, hypotension)</li>
                        <li><strong>Anticoagulation:</strong> Heparin bolus + infusion or enoxaparin</li>
                        <li><strong>High-intensity statin:</strong> Atorvastatin 80mg</li>
                    </ul>
                    <p><span class="label">P2Y12 Inhibitor:</span> Ticagrelor 180mg load (preferred) or clopidogrel 600mg load</p>
                    <p><span class="label">STEMI Specific:</span> Door-to-balloon <90 minutes. Call cath lab immediately. If PCI unavailable within 120 min, consider fibrinolytics (tPA, reteplase, tenecteplase)</p>
                    <p><span class="label">NSTEMI Specific:</span> Risk stratify with TIMI/GRACE. High-risk ‚Üí early invasive strategy (<24hr). Low-risk ‚Üí medical management, stress test before discharge</p>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>Sgarbossa Criteria:</strong> Diagnose STEMI with LBBB: ST elevation ‚â•1mm concordant with QRS (5 points), ST depression ‚â•1mm V1-V3 (3 points), ST elevation ‚â•5mm discordant (2 points). Score ‚â•3 = STEMI</li>
                    <li><strong>Wellens Syndrome:</strong> Biphasic or deep inverted T waves V2-V3 in pain-free patient = critical LAD stenosis, high risk of anterior STEMI. No stress test! Go to cath.</li>
                    <li><strong>RV Infarction Pearl:</strong> If inferior STEMI with hypotension, always get right-sided leads (V4R). Treat with aggressive IVF, avoid nitrates/diuretics</li>
                    <li><strong>Troponin timing:</strong> Can be negative first 2-4 hours. Serial troponins essential if high suspicion</li>
                    <li><strong>Don't forget:</strong> Type 2 MI (supply-demand mismatch from anemia, sepsis, tachyarrhythmia) - treat underlying cause, not necessarily cath</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>Hemodynamic instability (SBP <90, shock)</li>
                        <li>Malignant arrhythmias (VT/VF, high-grade AV block)</li>
                        <li>Mechanical complications (papillary rupture, VSD, free wall rupture)</li>
                        <li>Acute heart failure/cardiogenic shock</li>
                        <li>Need for pressors or mechanical support (IABP, Impella)</li>
                        <li>Post-cardiac arrest</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>Hemodynamically stable >24 hours</li>
                        <li>No recurrent chest pain</li>
                        <li>No arrhythmias requiring intervention</li>
                        <li>LVEF assessed (echo)</li>
                        <li>Successful revascularization (if indicated)</li>
                        <li>On DAPT, statin, Œ≤-blocker, ACE-I (if EF <40%)</li>
                        <li>Cardiac rehab referral arranged</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">COMPLICATIONS TO MONITOR</div>
                <div class="section-content">
                    <p><strong>Early (hours-days):</strong> Arrhythmias (VF, VT, bradycardia), cardiogenic shock, mechanical complications (papillary muscle rupture, VSD, free wall rupture), acute MR</p>
                    <p><strong>Late (days-weeks):</strong> Heart failure, LV thrombus, pericarditis (early: Dressler's syndrome 2-10 weeks), recurrent ischemia</p>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 2: HEART FAILURE EXACERBATION -->
        <div id="heart-failure" class="condition-page">
            <div class="page-header">
                <h2>2. ACUTE DECOMPENSATED HEART FAILURE</h2>
                <div class="subtitle">HFrEF ‚Ä¢ HFpEF ‚Ä¢ Acute Exacerbation</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Classic:</span> Progressive dyspnea, orthopnea, PND, lower extremity edema, weight gain. Physical exam: JVD, bibasilar rales, S3 gallop, peripheral edema, hepatomegaly.</p>
                    <p><span class="label">Alternate Presentations:</span></p>
                    <ul>
                        <li><strong>Flash Pulmonary Edema:</strong> Acute onset, often with HTN emergency, minimal peripheral edema</li>
                        <li><strong>High Output HF:</strong> Warm extremities, bounding pulses (thyrotoxicosis, AV fistula, severe anemia)</li>
                        <li><strong>RV Failure:</strong> Isolated lower extremity edema, ascites, hepatic congestion without pulmonary edema</li>
                        <li><strong>Elderly:</strong> Confusion, fatigue, decreased appetite may predominate over dyspnea</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">Labs:</span> BNP/NT-proBNP (BNP >400 or NT-proBNP >900 suggests HF), troponin (r/o ACS), BMP (assess renal function), CBC, Mg, TSH, LFTs</p>
                    <p><span class="label">Imaging:</span> CXR (cardiomegaly, pulmonary edema, pleural effusions), Echo (assess EF, valves, wall motion)</p>
                    <p><span class="label">ECG:</span> Look for ischemia, LVH, arrhythmias</p>
                    <p><span class="label">Calculations:</span> NYHA Class, EF%, fluid balance (daily weights), creatinine clearance</p>
                    <p><span class="label">Classify Hemodynamics:</span> Warm vs cold (perfusion), wet vs dry (volume status)</p>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL</div>
                <div class="section-content">
                    <p><span class="label">Initial Management:</span></p>
                    <ul>
                        <li><strong>O2:</strong> Maintain SpO2 >90%. Consider NIPPV (BiPAP/CPAP) if respiratory distress</li>
                        <li><strong>Diuresis (Wet):</strong> IV furosemide 40mg (or 2√ó home dose) bolus, then assess response. Consider continuous infusion if poor response. Goal negative 1-2L/day</li>
                        <li><strong>Vasodilators (if SBP >90):</strong> Nitroglycerin IV for afterload reduction, especially if hypertensive</li>
                        <li><strong>Sodium/Fluid Restriction:</strong> <2g sodium/day, <2L fluid/day</li>
                        <li><strong>Daily weights:</strong> Essential for monitoring</li>
                    </ul>
                    
                    <p><span class="label">Cold & Wet (Low Output):</span> Consider inotropes (dobutamine, milrinone) with invasive monitoring</p>
                    
                    <p><span class="label">Chronic HF Management (Initiate/Optimize):</span></p>
                    <ul>
                        <li><strong>HFrEF (EF <40%):</strong> Guideline-directed medical therapy (GDMT)</li>
                        <li>ACE-I/ARB or ARNI (sacubitril-valsartan)</li>
                        <li>Œ≤-blocker (carvedilol, metoprolol succinate, bisoprolol) - start low when stable</li>
                        <li>Aldosterone antagonist (spironolactone, eplerenone) if EF <35%</li>
                        <li>SGLT2 inhibitor (dapagliflozin, empagliflozin) - proven mortality benefit</li>
                        <li><strong>HFpEF (EF ‚â•50%):</strong> Treat HTN, AF, ischemia. SGLT2i now indicated</li>
                    </ul>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>BNP Pearls:</strong> Obesity lowers BNP. Renal failure raises it. Age-adjust NT-proBNP: <50yo: >450, 50-75yo: >900, >75yo: >1800</li>
                    <li><strong>Diuretic Resistance:</strong> If poor response to IV lasix, try: (1) Increase dose, (2) Continuous infusion, (3) Add thiazide (metolazone 2.5-5mg 30min before lasix), (4) Add acetazolamide</li>
                    <li><strong>Cardiorenal Syndrome:</strong> Cr bump with diuresis is often acceptable if congestion improving. Monitor BUN:Cr ratio (>20:1 suggests prerenal)</li>
                    <li><strong>Don't stop GDMT:</strong> Avoid stopping ACE-I/Œ≤-blocker acutely unless cardiogenic shock. Can hold during diuresis, restart before discharge</li>
                    <li><strong>B-type natriuretic peptide diuretics:</strong> Nesiritide (BNP analog) has no mortality benefit and increases hypotension - rarely used</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>Cardiogenic shock (SBP <90, cool extremities, AMS, oliguria)</li>
                        <li>Need for inotropes or mechanical support</li>
                        <li>Acute respiratory failure requiring intubation</li>
                        <li>Refractory pulmonary edema</li>
                        <li>Malignant arrhythmias</li>
                        <li>ACS with hemodynamic instability</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>Euvolemic (at or near dry weight)</li>
                        <li>No dyspnea at rest</li>
                        <li>Stable vital signs, O2 sat on room air</li>
                        <li>Transition to PO diuretics established</li>
                        <li>On optimized GDMT (HFrEF)</li>
                        <li>BMP stable, Cr at acceptable baseline</li>
                        <li>Patient education completed</li>
                        <li>Close follow-up arranged (within 7 days)</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">COMPLICATIONS TO MONITOR</div>
                <div class="section-content">
                    <p><strong>During Admission:</strong> Cardiorenal syndrome, electrolyte abnormalities (hypokalemia, hypomagnesemia, hyponatremia), arrhythmias (AF most common), worsening renal function</p>
                    <p><strong>Long-term:</strong> Recurrent admissions (50% at 6 months), progressive renal dysfunction, sudden cardiac death, need for advanced therapies (LVAD, transplant)</p>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 3: ATRIAL FIBRILLATION -->
        <div id="afib" class="condition-page">
            <div class="page-header">
                <h2>3. ATRIAL FIBRILLATION</h2>
                <div class="subtitle">RVR ‚Ä¢ New-Onset ‚Ä¢ Chronic AF Management</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Classic:</span> Palpitations, irregular pulse, dyspnea, chest discomfort, fatigue, lightheadedness. Irregularly irregular rhythm on exam.</p>
                    <p><span class="label">Alternate Presentations:</span></p>
                    <ul>
                        <li><strong>Asymptomatic:</strong> 30-40% discovered incidentally on exam or ECG</li>
                        <li><strong>Embolic stroke:</strong> First presentation in some patients</li>
                        <li><strong>Tachycardia-induced cardiomyopathy:</strong> Chronic RVR leading to heart failure</li>
                        <li><strong>Hyperthyroid AF:</strong> Lone AF in young patient, check TSH</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">Labs:</span> TSH (always), BMP, Mg, CBC, troponin (if chest pain), digoxin level (if on digoxin)</p>
                    <p><span class="label">Imaging:</span> ECG (confirm AF, assess rate, look for ischemia/WPW), CXR, TTE (assess for structural disease, valve disease, LV function, LA size)</p>
                    <p><span class="label">TEE:</span> Before cardioversion if AF >48hr or unknown duration (r/o LA thrombus), unless patient on therapeutic anticoagulation ‚â•3 weeks</p>
                    <p><span class="label">Calculations:</span></p>
                    <ul>
                        <li><strong>CHA‚ÇÇDS‚ÇÇ-VASc:</strong> Stroke risk (CHF, HTN, Age ‚â•75 [2pts], DM, Stroke/TIA [2pts], Vascular disease, Age 65-74, Sex [female]). Score ‚â•2 (‚ôÇ) or ‚â•3 (‚ôÄ) ‚Üí anticoagulate</li>
                        <li><strong>HAS-BLED:</strong> Bleeding risk (HTN, Abnormal renal/liver, Stroke, Bleeding, Labile INR, Elderly, Drugs/alcohol). Score ‚â•3 = high bleeding risk</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL</div>
                <div class="section-content">
                    <p><span class="label">Rate Control (First-line for most):</span></p>
                    <ul>
                        <li><strong>Œ≤-Blockers:</strong> Metoprolol 25-50mg PO q6h or 2.5-5mg IV, esmolol gtt (ICU). Goal HR <110 at rest</li>
                        <li><strong>Non-dihydropyridine CCB:</strong> Diltiazem 0.25mg/kg IV over 2min, then 5-15mg/hr gtt OR 30-60mg PO q6h</li>
                        <li><strong>Digoxin:</strong> 0.25mg IV/PO (less effective, use if HF or sedentary patients). Loading: 0.5mg ‚Üí 0.25mg q6h √ó 2</li>
                        <li><strong>Avoid:</strong> Œ≤-blockers and CCBs together (risk of heart block), rate control in WPW (can precipitate VF)</li>
                    </ul>
                    
                    <p><span class="label">Rhythm Control:</span></p>
                    <ul>
                        <li><strong>Indications:</strong> Hemodynamic instability, highly symptomatic despite rate control, first episode, young patient preference</li>
                        <li><strong>Cardioversion:</strong> If AF <48hr OR on anticoagulation ‚â•3 weeks OR TEE negative</li>
                        <li>Synchronized DC cardioversion: 120-200J biphasic (under sedation)</li>
                        <li>Chemical: Flecainide 300mg PO (if no CAD), ibutilide 1mg IV over 10min (monitor QT)</li>
                        <li><strong>Antiarrhythmics:</strong> Amiodarone (safest in structural disease), sotalol, dofetilide (in-hospital initiation)</li>
                    </ul>
                    
                    <p><span class="label">Anticoagulation:</span></p>
                    <ul>
                        <li><strong>CHA‚ÇÇDS‚ÇÇ-VASc ‚â•2 (‚ôÇ) or ‚â•3 (‚ôÄ):</strong> Anticoagulate (DOACs preferred over warfarin)</li>
                        <li><strong>DOACs:</strong> Apixaban, rivaroxaban, edoxaban, dabigatran (avoid if mechanical valve or severe MS)</li>
                        <li><strong>Post-cardioversion:</strong> Anticoagulate √ó 4 weeks minimum, longer if stroke risk factors</li>
                    </ul>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>WPW + AF = Emergency:</strong> Irregular wide-complex tachycardia. DO NOT use AV nodal blockers (can precipitate VF). Cardiovert or procainamide</li>
                    <li><strong>Rate vs Rhythm:</strong> AFFIRM/RACE trials show no mortality difference. Most patients do fine with rate control alone</li>
                    <li><strong>Anticoagulation paradox:</strong> HAS-BLED ‚â•3 means high bleeding risk, but often same patients who need anticoagulation most. Don't withhold if CHA‚ÇÇDS‚ÇÇ-VASc high</li>
                    <li><strong>Holiday Heart:</strong> Alcohol-induced AF. Often converts spontaneously with abstinence</li>
                    <li><strong>TEE before cardioversion:</strong> Even if on anticoagulation <3 weeks, consider TEE strategy to expedite cardioversion safely</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>Hemodynamic instability (SBP <90, shock)</li>
                        <li>Acute heart failure/pulmonary edema with RVR</li>
                        <li>Acute MI with RVR</li>
                        <li>Need for continuous IV rate control infusions</li>
                        <li>Post-cardioversion complications</li>
                        <li>RVR refractory to multiple agents</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>Rate controlled (HR <110 at rest, <120 with activity)</li>
                        <li>Hemodynamically stable ‚â•24 hours</li>
                        <li>Transitioned to oral rate control meds</li>
                        <li>Anticoagulation started (if indicated)</li>
                        <li>No signs of heart failure</li>
                        <li>Follow-up arranged (cardiology if new-onset)</li>
                        <li>If cardioverted: Stable rhythm ‚â•24hr</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">COMPLICATIONS TO MONITOR</div>
                <div class="section-content">
                    <p><strong>Acute:</strong> Stroke/TIA (most feared), hemodynamic compromise, heart failure, ACS (demand ischemia from RVR)</p>
                    <p><strong>Chronic:</strong> Tachycardia-induced cardiomyopathy (EF improves with rate/rhythm control), thromboembolism, bleeding (if anticoagulated)</p>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 4: HYPERTENSIVE EMERGENCY -->
        <div id="htn-emergency" class="condition-page">
            <div class="page-header">
                <h2>4. HYPERTENSIVE EMERGENCY</h2>
                <div class="subtitle">End-Organ Damage ‚Ä¢ ICU Management</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Definition:</span> Severe hypertension (typically SBP >180 or DBP >120) WITH acute end-organ damage</p>
                    <p><span class="label">Classic:</span> Severe headache, visual changes, chest pain, dyspnea, altered mental status, focal neurologic deficits</p>
                    <p><span class="label">Alternate Presentations:</span></p>
                    <ul>
                        <li><strong>Neurologic:</strong> Hypertensive encephalopathy (HA, confusion, seizures), stroke (ischemic/hemorrhagic), PRES</li>
                        <li><strong>Cardiac:</strong> Acute MI, acute pulmonary edema, aortic dissection</li>
                        <li><strong>Renal:</strong> Acute kidney injury, hematuria, proteinuria</li>
                        <li><strong>Microangiopathic:</strong> Hemolytic anemia, thrombocytopenia</li>
                    </ul>
                    <p><span class="label">Hypertensive Urgency:</span> Severe HTN WITHOUT end-organ damage. Managed outpatient with PO meds</p>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">Labs:</span> BMP, troponin, CBC, UA, peripheral smear if hemolysis suspected, BNP if APE concern</p>
                    <p><span class="label">Imaging:</span> ECG, CXR, Head CT if neuro symptoms, CT chest if dissection suspected</p>
                    <p><span class="label">Fundoscopic:</span> Look for papilledema, hemorrhages, exudates</p>
                    <p><span class="label">Calculate Target BP:</span> Initial reduction 10-20% in 1st hour, then 5-15% over next 23 hours. Avoid >25% reduction in first 24hr</p>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL</div>
                <div class="section-content">
                    <p><span class="label">General:</span> ICU admission, continuous BP monitoring (arterial line often needed), IV antihypertensives</p>
                    <p><span class="label">IV Agents:</span></p>
                    <ul>
                        <li><strong>Nicardipine:</strong> 5mg/hr, titrate by 2.5mg/hr q5-15min (max 15mg/hr). First-line</li>
                        <li><strong>Labetalol:</strong> 20mg IV bolus, then 20-80mg q10min OR 0.5-2mg/min infusion</li>
                        <li><strong>Clevidipine:</strong> 1-2mg/hr, double q90sec (max 21mg/hr). Short-acting</li>
                        <li><strong>Esmolol:</strong> Œ≤-blocker for dissection. 500mcg/kg load, then 50-300mcg/kg/min</li>
                        <li><strong>Nitroprusside:</strong> 0.25-10mcg/kg/min. For APE. Watch cyanide toxicity</li>
                    </ul>
                    <p><span class="label">Specific Scenarios:</span></p>
                    <ul>
                        <li><strong>Aortic Dissection:</strong> SBP <120 in 20min. Esmolol FIRST, then nicardipine</li>
                        <li><strong>Ischemic Stroke:</strong> Permissive HTN! Allow SBP up to 220 (or 185 if tPA)</li>
                        <li><strong>Hemorrhagic Stroke:</strong> Goal SBP 140-160</li>
                        <li><strong>Eclampsia:</strong> Mag sulfate + hydralazine/labetalol. Deliver baby!</li>
                    </ul>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>Urgency vs Emergency:</strong> Only EMERGENCY needs ICU/IV meds. Urgency = oral meds over hours-days</li>
                    <li><strong>Don't drop too fast:</strong> Cerebral autoregulation reset in chronic HTN. Rapid drop ‚Üí stroke/MI</li>
                    <li><strong>Ischemic stroke exception:</strong> Brain needs perfusion! Only lower if SBP >220 or giving tPA</li>
                    <li><strong>PRES:</strong> Headache, confusion, seizures, vision loss + posterior white matter edema. Usually reversible</li>
                    <li><strong>Transition to PO:</strong> Start long-acting oral agents before stopping IV to prevent rebound</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>ALL hypertensive emergencies require ICU</li>
                        <li>Need for continuous IV infusion</li>
                        <li>Acute end-organ damage</li>
                        <li>Altered mental status</li>
                        <li>Arterial line needed</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>BP controlled on oral regimen ‚â•24hr</li>
                        <li>End-organ damage stabilized</li>
                        <li>Off IV medications</li>
                        <li>Patient educated on compliance</li>
                        <li>Close follow-up arranged (within 1 week)</li>
                        <li>Secondary causes evaluated if indicated</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">COMPLICATIONS TO MONITOR</div>
                <div class="section-content">
                    <p><strong>From Hypertension:</strong> Stroke, MI, aortic dissection, acute renal failure, retinopathy, heart failure</p>
                    <p><strong>From Treatment:</strong> Hypotension, stroke from rapid BP drop, rebound HTN, cyanide toxicity (nitroprusside)</p>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 5: COMMUNITY-ACQUIRED PNEUMONIA -->
        <div id="cap" class="condition-page">
            <div class="page-header">
                <h2>5. COMMUNITY-ACQUIRED PNEUMONIA (CAP)</h2>
                <div class="subtitle">Outpatient ‚Ä¢ Inpatient ‚Ä¢ ICU Management</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Classic:</span> Fever, cough (productive/dry), dyspnea, pleuritic chest pain. Exam: Tachypnea, rales/crackles, bronchial breath sounds, dullness, egophony</p>
                    <p><span class="label">Alternate Presentations:</span></p>
                    <ul>
                        <li><strong>Elderly:</strong> Minimal fever, confusion/delirium, weakness, falls. May lack respiratory symptoms</li>
                        <li><strong>Atypical Organisms:</strong> Dry cough, headache, myalgias, diarrhea (Legionella, Mycoplasma)</li>
                        <li><strong>Aspiration:</strong> Witnessed event, right lower lobe/posterior segments, foul sputum</li>
                        <li><strong>Immunocompromised:</strong> PCP, CMV, TB</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">Imaging:</span> CXR (PA and lateral) - infiltrate confirms diagnosis</p>
                    <p><span class="label">Labs (if admitted):</span> CBC, BMP, procalcitonin, blood cultures √ó 2, sputum Gram stain/culture, ABG if hypoxic</p>
                    <p><span class="label">Special:</span> Legionella urinary Ag, Strep pneumo urinary Ag (if severe), respiratory viral panel, HIV if risk factors</p>
                    <p><span class="label">Severity Scores:</span></p>
                    <ul>
                        <li><strong>CURB-65:</strong> Confusion, Urea >20, RR ‚â•30, BP (SBP <90 or DBP ‚â§60), Age ‚â•65. Score 0-1: outpatient, 2: admit, ‚â•3: ICU</li>
                        <li><strong>PSI/PORT:</strong> More complex. Classes I-II outpatient, III consider admit, IV-V admit</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL</div>
                <div class="section-content">
                    <p><span class="label">Outpatient (CURB-65 0-1):</span></p>
                    <ul>
                        <li><strong>Previously healthy:</strong> Amoxicillin 1g TID √ó 5d OR doxycycline 100mg BID √ó 5d</li>
                        <li><strong>With comorbidities:</strong> Amoxicillin-clavulanate + macrolide OR levofloxacin 750mg daily</li>
                    </ul>
                    
                    <p><span class="label">Inpatient Non-ICU:</span></p>
                    <ul>
                        <li><strong>Standard:</strong> Ceftriaxone 1-2g IV daily + azithromycin 500mg IV/PO daily</li>
                        <li><strong>Alternative:</strong> Levofloxacin 750mg daily or moxifloxacin 400mg daily</li>
                        <li><strong>Duration:</strong> Minimum 5 days if afebrile √ó 48-72hr and stable</li>
                    </ul>
                    
                    <p><span class="label">ICU (Severe CAP):</span></p>
                    <ul>
                        <li><strong>Standard:</strong> Ceftriaxone 2g IV daily + azithromycin 500mg IV daily</li>
                        <li><strong>MRSA Risk:</strong> Add vancomycin or linezolid</li>
                        <li><strong>Pseudomonas Risk:</strong> Pip-tazo or cefepime + fluoroquinolone</li>
                    </ul>
                    
                    <p><span class="label">Supportive:</span> O2 to SpO2 >90%, IV fluids, VTE prophylaxis</p>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>Legionella clues:</strong> Hyponatremia, elevated LFTs, GI symptoms, relative bradycardia. Urinary antigen test. Need 10-14d abx</li>
                    <li><strong>PCP Pneumonia:</strong> Subacute, dry cough, exertional dyspnea in HIV. Bilateral interstitial infiltrates. LDH >500. TMP-SMX + prednisone if PaO2 <70</li>
                    <li><strong>Step-down criteria:</strong> HR <100, RR <24, SBP >90, SpO2 >90%, temp <37.8¬∞C, able to take PO</li>
                    <li><strong>Macrolide resistance:</strong> S. pneumoniae resistance ~30-40%. Always pair with Œ≤-lactam for inpatients</li>
                    <li><strong>Vaccines:</strong> PPSV23 and PCV20 after recovery per CDC schedule</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>Severe CAP (CURB-65 ‚â•3)</li>
                        <li>Need for mechanical ventilation</li>
                        <li>Septic shock requiring pressors</li>
                        <li>Multilobar infiltrates</li>
                        <li>PaO2/FiO2 <250</li>
                        <li>Confusion, AMS</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>Afebrile √ó 48-72 hours</li>
                        <li>Hemodynamically stable</li>
                        <li>O2 sat >90% on room air/baseline</li>
                        <li>Able to tolerate PO</li>
                        <li>Completed minimum 5 days antibiotics</li>
                        <li>Follow-up CXR arranged (6 weeks)</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">COMPLICATIONS TO MONITOR</div>
                <div class="section-content">
                    <p><strong>Early:</strong> Respiratory failure, sepsis/septic shock, parapneumonic effusion, empyema, lung abscess</p>
                    <p><strong>Late:</strong> Organizing pneumonia, fibrosis, recurrent pneumonia (consider malignancy)</p>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 6: COPD EXACERBATION -->
        <div id="copd" class="condition-page">
            <div class="page-header">
                <h2>6. COPD EXACERBATION</h2>
                <div class="subtitle">AECOPD ‚Ä¢ Acute on Chronic</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Classic:</span> Increased dyspnea, cough, sputum production/purulence beyond baseline. Wheezing, accessory muscle use, pursed-lip breathing</p>
                    <p><span class="label">Anthonisen Criteria:</span> (1) Increased dyspnea, (2) Increased sputum volume, (3) Increased sputum purulence. Type I = all 3, Type II = 2 of 3, Type III = 1 symptom</p>
                    <p><span class="label">Alternate Presentations:</span></p>
                    <ul>
                        <li><strong>Hypercapnic Encephalopathy:</strong> Confusion, asterixis, somnolence from CO2 retention</li>
                        <li><strong>Right Heart Failure:</strong> Peripheral edema, JVD from cor pulmonale</li>
                        <li><strong>Elderly:</strong> Fatigue, decreased functional status, falls</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">Labs:</span> ABG (assess hypercapnia, acidosis), CBC, BMP, BNP if HF concern, sputum culture if severe/recurrent</p>
                    <p><span class="label">Imaging:</span> CXR (r/o pneumonia, PTX, CHF), consider CT if recurrent or PE concern</p>
                    <p><span class="label">ECG:</span> Evaluate for MI, arrhythmia, right heart strain</p>
                    <p><span class="label">Calculations:</span> A-a gradient, FiO2 requirements</p>
                    <p><span class="label">Triggers:</span> Infection (most common), medication noncompliance, PE, pneumothorax, MI, pneumonia</p>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL</div>
                <div class="section-content">
                    <p><span class="label">Bronchodilators:</span></p>
                    <ul>
                        <li><strong>SABA:</strong> Albuterol 2.5-5mg nebulized q4h or continuous</li>
                        <li><strong>SAMA:</strong> Ipratropium 0.5mg nebulized q6h OR combined albuterol-ipratropium (DuoNeb)</li>
                        <li>Note: Ipratropium added to albuterol shows additive benefit in COPD (unlike asthma)</li>
                    </ul>
                    
                    <p><span class="label">Systemic Corticosteroids:</span></p>
                    <ul>
                        <li><strong>Dose:</strong> Prednisone 40mg PO daily √ó 5 days (or methylprednisolone 125mg IV if severe/unable PO)</li>
                        <li><strong>Evidence:</strong> 5-7 days as effective as longer courses with fewer side effects</li>
                    </ul>
                    
                    <p><span class="label">Antibiotics (if ‚â•2 cardinal symptoms or purulent sputum):</span></p>
                    <ul>
                        <li><strong>First-line:</strong> Azithromycin 500mg daily √ó 5d OR doxycycline 100mg BID √ó 5-7d</li>
                        <li><strong>Second-line:</strong> Amoxicillin-clavulanate, respiratory fluoroquinolone, cephalosporin</li>
                        <li><strong>Pseudomonas risk:</strong> (FEV1 <50%, recent hospitalization, >4 exacerbations/year) ‚Üí fluoroquinolone or cephalosporin</li>
                    </ul>
                    
                    <p><span class="label">Oxygen Therapy:</span> Goal SpO2 88-92% (avoid higher - can worsen hypercapnia). Titrate carefully in CO2 retainers</p>
                    
                    <p><span class="label">Ventilatory Support:</span></p>
                    <ul>
                        <li><strong>NIPPV (BiPAP):</strong> First-line for hypercapnic respiratory failure (pH 7.25-7.35). Reduces intubation rate and mortality</li>
                        <li><strong>Intubation:</strong> If unable to tolerate NIPPV, worsening acidosis (pH <7.25), decreased mental status</li>
                    </ul>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>O2-induced hypercapnia:</strong> High O2 in COPD ‚Üí worsens V/Q mismatch and Haldane effect ‚Üí CO2 retention. Keep SpO2 88-92%</li>
                    <li><strong>BiPAP is magic:</strong> NIPPV reduces intubation by 65%, mortality by 55% in AECOPD with respiratory acidosis. Use early!</li>
                    <li><strong>Steroid duration:</strong> REDUCE trial showed 5 days = 14 days for outcomes. Don't give longer courses</li>
                    <li><strong>Antibiotics debate:</strong> Only benefit if purulent sputum or ‚â•2 cardinal symptoms. Type III (1 symptom) may not need abx</li>
                    <li><strong>Home oxygen criteria:</strong> Resting PaO2 <55 or SpO2 <88% OR PaO2 56-59 with cor pulmonale/polycythemia</li>
                    <li><strong>Prevention:</strong> Vaccinations (flu, pneumococcal), smoking cessation, maintenance inhalers, pulmonary rehab</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>Severe respiratory acidosis (pH <7.30)</li>
                        <li>Need for intubation/mechanical ventilation</li>
                        <li>Hemodynamic instability</li>
                        <li>Altered mental status despite treatment</li>
                        <li>Failed NIPPV trial on floor</li>
                        <li>Life-threatening comorbidity (MI, sepsis)</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>Return to baseline dyspnea/function</li>
                        <li>Tolerating SABA q4h or less</li>
                        <li>SpO2 >90% on room air or baseline O2</li>
                        <li>Able to sleep and walk without severe dyspnea</li>
                        <li>pH >7.35 if acidotic on admission</li>
                        <li>On maintenance inhalers (LABA/LAMA combo)</li>
                        <li>Inhaler technique verified</li>
                        <li>Pulmonary follow-up within 1 month</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">COMPLICATIONS TO MONITOR</div>
                <div class="section-content">
                    <p><strong>Acute:</strong> Respiratory failure requiring intubation, pneumothorax (bullous disease), pneumonia, arrhythmias, myocardial ischemia</p>
                    <p><strong>Chronic:</strong> Cor pulmonale, progressive lung function decline, long-term oxygen need, recurrent exacerbations</p>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 7: ASTHMA EXACERBATION -->
        <div id="asthma" class="condition-page">
            <div class="page-header">
                <h2>7. ASTHMA EXACERBATION</h2>
                <div class="subtitle">Acute Bronchospasm ‚Ä¢ Status Asthmaticus</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Classic:</span> Dyspnea, wheezing, chest tightness, cough, accessory muscle use, prolonged expiration</p>
                    <p><span class="label">Alternate Presentations:</span></p>
                    <ul>
                        <li><strong>Silent Chest:</strong> Severe obstruction with minimal air movement - ominous sign!</li>
                        <li><strong>Cough-Variant Asthma:</strong> Persistent cough without wheezing</li>
                        <li><strong>Exercise-Induced:</strong> Symptoms during/after exercise</li>
                        <li><strong>Children:</strong> May present with only cough or difficulty feeding</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">Immediate:</span> Peak flow, O2 saturation, vital signs</p>
                    <p><span class="label">If Severe:</span> CXR (r/o pneumothorax, infiltrate), ABG if critically ill, VBG acceptable</p>
                    <p><span class="label">Calculations:</span> Peak flow % predicted (compare to personal best), FEV1 if available</p>
                    <p><span class="label">Severity Assessment:</span></p>
                    <ul>
                        <li><strong>Mild:</strong> Speaks full sentences, HR <100, PEF >70%</li>
                        <li><strong>Moderate:</strong> Speaks phrases, HR 100-120, PEF 40-70%</li>
                        <li><strong>Severe:</strong> Speaks words, HR >120, PEF <40%, accessory muscles</li>
                        <li><strong>Life-threatening:</strong> Unable to speak, altered mental status, silent chest, bradycardia, hypotension</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL</div>
                <div class="section-content">
                    <p><span class="label">Bronchodilators:</span></p>
                    <ul>
                        <li><strong>Albuterol:</strong> 2.5-5mg nebulized q20min √ó 3, then reassess. Consider continuous nebulization if severe</li>
                        <li><strong>Ipratropium:</strong> 0.5mg nebulized √ó 3 doses (add to albuterol for moderate-severe exacerbations)</li>
                    </ul>
                    
                    <p><span class="label">Systemic Corticosteroids (ALL patients except mildest):</span></p>
                    <ul>
                        <li><strong>Prednisone:</strong> 40-60mg PO daily √ó 5 days OR</li>
                        <li><strong>Methylprednisolone:</strong> 125mg IV if unable to take PO or severe</li>
                        <li>No taper needed for short course</li>
                    </ul>
                    
                    <p><span class="label">Oxygen:</span> Maintain SpO2 >90%</p>
                    
                    <p><span class="label">Severe/Refractory (not responding to above):</span></p>
                    <ul>
                        <li><strong>Magnesium sulfate:</strong> 2g IV over 20 minutes (relaxes bronchial smooth muscle)</li>
                        <li><strong>Epinephrine:</strong> 0.3-0.5mg IM (or subQ) if anaphylaxis component or impending respiratory failure</li>
                        <li><strong>Terbutaline:</strong> 0.25mg subQ (use with caution - cardiac side effects)</li>
                        <li><strong>Heliox:</strong> May reduce work of breathing (helium-oxygen mixture)</li>
                    </ul>
                    
                    <p><span class="label">Do NOT Give:</span> Sedatives (can suppress respiratory drive), antibiotics (unless clear bacterial infection)</p>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>Silent chest = BAD:</strong> Means severe obstruction with minimal air movement. This is life-threatening!</li>
                    <li><strong>Ipratropium in asthma:</strong> Unlike COPD, only add for moderate-severe exacerbations (first 3 doses only)</li>
                    <li><strong>Magnesium mechanism:</strong> Competes with calcium in smooth muscle ‚Üí bronchodilation. Number needed to treat = 8</li>
                    <li><strong>Normal PCO2 is concerning:</strong> Asthma patients should be hypocapnic (from hyperventilation). Normal/high CO2 = respiratory fatigue</li>
                    <li><strong>Steroid timing:</strong> Takes 4-6 hours to work. Give early! Don't wait for severe deterioration</li>
                    <li><strong>Discharge medication:</strong> Always send home with short course PO steroids, albuterol inhaler, and controller if not already on one</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>Status asthmaticus (not improving despite aggressive treatment)</li>
                        <li>Respiratory failure requiring intubation</li>
                        <li>Altered mental status, confusion, lethargy</li>
                        <li>Silent chest</li>
                        <li>PCO2 >45 (respiratory fatigue)</li>
                        <li>Need for continuous nebulization</li>
                        <li>Hemodynamic instability</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>PEF or FEV1 >70% predicted or personal best</li>
                        <li>SpO2 >90% on room air</li>
                        <li>No accessory muscle use, speaks full sentences</li>
                        <li>Sustained improvement ‚â•60 min after last treatment</li>
                        <li>On appropriate controller medication</li>
                        <li>Has action plan and follow-up arranged</li>
                        <li>Prescribed albuterol + oral steroids √ó 5 days</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">COMPLICATIONS TO MONITOR</div>
                <div class="section-content">
                    <p><strong>Acute:</strong> Status asthmaticus, respiratory failure, pneumothorax, pneumomediastinum, cardiac arrest</p>
                    <p><strong>Iatrogenic:</strong> Hypokalemia (from Œ≤-agonists), tremor, tachycardia, hyperglycemia (from steroids)</p>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 8: PULMONARY EMBOLISM -->
        <div id="pe" class="condition-page">
            <div class="page-header">
                <h2>8. PULMONARY EMBOLISM (PE)</h2>
                <div class="subtitle">VTE ‚Ä¢ Massive PE ‚Ä¢ Submassive PE</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Classic:</span> Dyspnea, pleuritic chest pain, tachycardia, tachypnea, hemoptysis, unilateral leg swelling</p>
                    <p><span class="label">Alternate Presentations:</span></p>
                    <ul>
                        <li><strong>Massive PE:</strong> Hypotension, syncope, cardiac arrest (obstructive shock)</li>
                        <li><strong>Submassive PE:</strong> Hemodynamically stable but RV strain on echo or biomarkers</li>
                        <li><strong>Chronic PE:</strong> Progressive dyspnea, may be misdiagnosed as heart failure</li>
                        <li><strong>Small PE:</strong> May be asymptomatic or minimal symptoms</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">Calculate Pre-test Probability:</span> Wells Score or PERC Rule (see calculators below)</p>
                    <p><span class="label">Labs:</span> D-dimer (if low probability - high sensitivity, low specificity), troponin, BNP (assess RV strain), ABG (may show hypoxemia, A-a gradient)</p>
                    <p><span class="label">Imaging:</span></p>
                    <ul>
                        <li><strong>CTPA (CT Pulmonary Angiography):</strong> Gold standard, shows filling defects</li>
                        <li><strong>V/Q Scan:</strong> If contrast contraindicated</li>
                        <li><strong>Lower Extremity Doppler US:</strong> Look for DVT source</li>
                        <li><strong>Echo:</strong> Assess RV function, strain (McConnell's sign = RV dysfunction with apical sparing)</li>
                    </ul>
                    <p><span class="label">ECG:</span> Sinus tachycardia most common. Classic S1Q3T3 pattern rare. Right heart strain pattern</p>
                    
                    <!-- Wells Score Calculator -->
                    <div id="calc-wells-pe" class="calculator">
                        <div class="calculator-title">üßÆ Wells Score for PE</div>
                        <div class="calc-description">
                            <strong>Use:</strong> Pre-test probability of PE. Score ‚â§4 = PE unlikely (consider D-dimer), >4 = PE likely (proceed to CTPA).
                        </div>
                        
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="wells-dvt"> Clinical signs of DVT
                                <span class="hint">Leg swelling, unilateral pain (+3 points)</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="wells-alt"> PE most likely diagnosis (no alternative)
                                <span class="hint">+3 points</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="wells-hr"> Heart rate >100 bpm
                                <span class="hint">+1.5 points</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="wells-immob"> Immobilization ‚â•3 days or surgery within 4 weeks
                                <span class="hint">+1.5 points</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="wells-prior"> Previous DVT or PE
                                <span class="hint">+1.5 points</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="wells-hemo"> Hemoptysis
                                <span class="hint">+1 point</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="wells-cancer"> Malignancy (treatment within 6 months or palliative)
                                <span class="hint">+1 point</span>
                            </label>
                        </div>
                        
                        <button class="calc-button" onclick="calculateWells()">Calculate Wells Score</button>
                        <div id="wells-result"></div>
                    </div>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL</div>
                <div class="section-content">
                    <p><span class="label">Anticoagulation (Most Patients):</span></p>
                    <ul>
                        <li><strong>LMWH:</strong> Enoxaparin 1mg/kg subQ q12h (preferred if renal function normal)</li>
                        <li><strong>Unfractionated Heparin:</strong> 80 units/kg bolus, then 18 units/kg/hr infusion (if CrCl <30 or high bleeding risk)</li>
                        <li><strong>Fondaparinux:</strong> Weight-based subQ dosing</li>
                        <li><strong>DOACs:</strong> Rivaroxaban or apixaban can be started immediately (no bridging needed)</li>
                    </ul>
                    
                    <p><span class="label">Thrombolytics (Massive PE with hemodynamic instability):</span></p>
                    <ul>
                        <li><strong>Indications:</strong> SBP <90 for >15 min OR shock requiring pressors OR cardiac arrest</li>
                        <li><strong>Alteplase (tPA):</strong> 100mg IV over 2 hours OR 0.6mg/kg over 15 min (max 50mg)</li>
                        <li><strong>Contraindications:</strong> Recent surgery, active bleeding, stroke, intracranial pathology</li>
                    </ul>
                    
                    <p><span class="label">Catheter-Directed Therapy:</span> For submassive PE with RV dysfunction but contraindications to systemic lysis</p>
                    
                    <p><span class="label">IVC Filter:</span> Only if absolute contraindication to anticoagulation (active bleeding)</p>
                    
                    <p><span class="label">Supportive:</span> O2, judicious IVF (avoid overload - worsens RV strain), pressors if shock</p>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>PERC Rule:</strong> If all 8 criteria negative (age <50, HR <100, SpO2 ‚â•95%, no hemoptysis, no estrogen, no prior VTE, no surgery/trauma, no unilateral leg swelling) AND low clinical suspicion ‚Üí PE excluded, no D-dimer needed</li>
                    <li><strong>D-dimer pitfalls:</strong> Elevated in many conditions (infection, cancer, pregnancy, age >50). Only useful to rule OUT PE in low-probability patients</li>
                    <li><strong>Massive vs Submassive:</strong> Massive = hypotension/shock (needs thrombolytics). Submassive = RV strain but stable BP (controversial management)</li>
                    <li><strong>Anticoagulation duration:</strong> Provoked (surgery, trauma) = 3 months. Unprovoked or cancer = ‚â•6 months, consider indefinite</li>
                    <li><strong>Don't give IVF blindly:</strong> PE is RV failure - RV already volume overloaded. Excessive fluids worsen RV strain</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>Massive PE (hypotension, shock)</li>
                        <li>Submassive PE with worsening RV function</li>
                        <li>Need for thrombolytics or mechanical intervention</li>
                        <li>Hemodynamic instability</li>
                        <li>Respiratory failure</li>
                        <li>Cardiac arrest</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>Hemodynamically stable ‚â•24 hours</li>
                        <li>O2 sat >90% on room air or baseline</li>
                        <li>No RV dysfunction or resolved</li>
                        <li>Adequate pain control</li>
                        <li>On therapeutic anticoagulation</li>
                        <li>Safe for outpatient management (PESI score)</li>
                        <li>Follow-up arranged with anticoagulation clinic</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">COMPLICATIONS TO MONITOR</div>
                <div class="section-content">
                    <p><strong>Acute:</strong> RV failure, cardiac arrest, recurrent PE, bleeding (from anticoagulation)</p>
                    <p><strong>Chronic:</strong> Chronic thromboembolic pulmonary hypertension (CTEPH), post-thrombotic syndrome</p>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 9: SEPSIS/SEPTIC SHOCK -->
        <div id="sepsis" class="condition-page">
            <div class="page-header">
                <h2>9. SEPSIS/SEPTIC SHOCK</h2>
                <div class="subtitle">Life-Threatening Organ Dysfunction ‚Ä¢ Sepsis-3</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Sepsis Definition (Sepsis-3):</span> Life-threatening organ dysfunction caused by dysregulated host response to infection. SOFA score ‚â•2</p>
                    <p><span class="label">Classic:</span> Fever/hypothermia, tachycardia, tachypnea, altered mental status, hypotension</p>
                    <p><span class="label">Alternate Presentations:</span></p>
                    <ul>
                        <li><strong>Elderly:</strong> May lack fever, present with confusion or falls only</li>
                        <li><strong>Immunocompromised:</strong> Blunted fever response, rapid progression</li>
                        <li><strong>Cryptic Shock:</strong> Normal BP but elevated lactate (tissue hypoperfusion)</li>
                        <li><strong>Cold Sepsis:</strong> Hypothermia, cool extremities (late, poor prognosis)</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">Labs:</span> Blood cultures √ó 2 (different sites, before antibiotics), CBC, CMP, lactate (repeat q2-4h), procalcitonin, coagulation studies</p>
                    <p><span class="label">Source Identification:</span> UA/urine culture, CXR, wound cultures, consider abdominal imaging if source unclear</p>
                    <p><span class="label">Calculate:</span> qSOFA score (see below), SOFA score, lactate clearance</p>
                    
                    <!-- qSOFA Calculator -->
                    <div id="calc-qsofa" class="calculator">
                        <div class="calculator-title">üßÆ qSOFA Calculator</div>
                        <div class="calc-description">
                            <strong>Use:</strong> Quick screening for sepsis outside ICU. Score ‚â•2 suggests high risk for poor outcomes. NOT diagnostic, but prompts further evaluation.
                        </div>
                        
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="qsofa-rr"> Respiratory Rate ‚â•22/min
                                <span class="hint">+1 point</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="qsofa-ams"> Altered Mental Status (GCS <15)
                                <span class="hint">Any confusion, disorientation, or decreased LOC (+1 point)</span>
                            </label>
                        </div>
                        <div class="calc-item checkbox-item">
                            <label><input type="checkbox" id="qsofa-sbp"> Systolic BP ‚â§100 mmHg
                                <span class="hint">+1 point</span>
                            </label>
                        </div>
                        
                        <button class="calc-button" onclick="calculateQSOFA()">Calculate qSOFA Score</button>
                        <div id="qsofa-result"></div>
                    </div>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL (Sepsis Bundle - Within 1 Hour)</div>
                <div class="section-content">
                    <p><span class="label">1. Measure Lactate:</span> Remeasure if initial lactate >2 mmol/L</p>
                    
                    <p><span class="label">2. Obtain Blood Cultures BEFORE Antibiotics:</span> But don't delay antibiotics >45 min</p>
                    
                    <p><span class="label">3. Administer Broad-Spectrum Antibiotics:</span></p>
                    <ul>
                        <li><strong>Sepsis (no source identified):</strong> Vancomycin + pip-tazo OR cefepime + metronidazole</li>
                        <li><strong>Pulmonary source:</strong> Vancomycin + cefepime (or pip-tazo)</li>
                        <li><strong>Abdominal source:</strong> Pip-tazo OR ceftriaxone + metronidazole</li>
                        <li><strong>Urinary source:</strong> Ceftriaxone or fluoroquinolone (add ampicillin if Enterococcus risk)</li>
                        <li><strong>Skin/soft tissue:</strong> Vancomycin + pip-tazo</li>
                        <li><strong>Immunocompromised:</strong> Add antifungal (micafungin) and consider antivirals</li>
                    </ul>
                    
                    <p><span class="label">4. Rapid Administration of 30 mL/kg Crystalloid for Hypotension or Lactate ‚â•4:</span></p>
                    <ul>
                        <li>Use balanced crystalloids (LR or Plasma-Lyte) preferred over NS</li>
                        <li>Reassess after fluid bolus - repeat PRN based on hemodynamics</li>
                    </ul>
                    
                    <p><span class="label">5. Vasopressors if Hypotensive During or After Fluid Resuscitation:</span></p>
                    <ul>
                        <li><strong>Norepinephrine:</strong> First-line, start 0.05-0.1 mcg/kg/min, titrate to MAP ‚â•65</li>
                        <li><strong>Vasopressin:</strong> Add 0.03-0.04 units/min if inadequate response</li>
                        <li><strong>Epinephrine:</strong> Second-line if refractory</li>
                        <li><strong>Phenylephrine:</strong> Only if tachyarrhythmia or norepinephrine shortage</li>
                    </ul>
                    
                    <p><span class="label">Source Control:</span> Drain abscesses, remove infected devices, debride necrotic tissue - within 6-12 hours</p>
                    
                    <p><span class="label">Additional Considerations:</span></p>
                    <ul>
                        <li><strong>Stress-dose steroids:</strong> Hydrocortisone 200mg/day if refractory shock despite fluids + pressors</li>
                        <li><strong>Avoid:</strong> Hetastarch, gelatin (increase mortality), albumin for routine resuscitation</li>
                    </ul>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>Sepsis-3 vs Old Criteria:</strong> No more SIRS criteria. Focus on organ dysfunction (SOFA ‚â•2). qSOFA is screening tool, not diagnostic</li>
                    <li><strong>Time is tissue:</strong> Every hour delay in antibiotics increases mortality by 7.6%. Door-to-antibiotic <1 hour!</li>
                    <li><strong>Lactate clearance:</strong> >10% reduction in lactate within 2-4 hours associated with improved survival. Trend it!</li>
                    <li><strong>Balanced crystalloids:</strong> LR/Plasma-Lyte associated with lower mortality than NS. NS causes hyperchloremic acidosis</li>
                    <li><strong>Early vasopressors OK:</strong> Don't wait to "finish" 30cc/kg if patient still hypotensive. Start pressors concurrently</li>
                    <li><strong>Procalcitonin use:</strong> Can help determine if infection present and guide antibiotic duration. <0.5 = low likelihood bacterial</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>ALL septic shock (hypotension requiring pressors)</li>
                        <li>Lactate ‚â•4 mmol/L</li>
                        <li>Respiratory failure requiring ventilation</li>
                        <li>Acute mental status changes</li>
                        <li>Oliguria/anuria despite fluids</li>
                        <li>Multiorgan dysfunction</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>Afebrile √ó 24-48 hours</li>
                        <li>Hemodynamically stable off pressors ‚â•24hr</li>
                        <li>Lactate normalized</li>
                        <li>Source controlled</li>
                        <li>Mental status at baseline</li>
                        <li>Tolerating PO, able to take antibiotics</li>
                        <li>No new organ dysfunction</li>
                        <li>Close follow-up arranged</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">COMPLICATIONS TO MONITOR</div>
                <div class="section-content">
                    <p><strong>Acute:</strong> ARDS, AKI requiring dialysis, DIC, multiorgan failure, cardiac dysfunction, death (mortality 10-40%)</p>
                    <p><strong>Long-term:</strong> Post-sepsis syndrome (cognitive impairment, weakness, PTSD), recurrent infections, chronic organ dysfunction</p>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 10: ACUTE KIDNEY INJURY -->
        <div id="aki" class="condition-page">
            <div class="page-header">
                <h2>10. ACUTE KIDNEY INJURY (AKI)</h2>
                <div class="subtitle">Prerenal ‚Ä¢ Intrinsic ‚Ä¢ Postrenal</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Definition:</span> Increase in Cr ‚â•0.3 mg/dL within 48hr OR increase to ‚â•1.5√ó baseline OR urine output <0.5 mL/kg/hr for 6hr</p>
                    <p><span class="label">Classic:</span> Oliguria, fluid overload, edema, uremic symptoms (N/V, confusion, asterixis, pericarditis)</p>
                    <p><span class="label">Alternate Presentations:</span></p>
                    <ul>
                        <li><strong>Non-oliguric AKI:</strong> Cr rising but urine output preserved (often ATN from nephrotoxins)</li>
                        <li><strong>Hyperkalemia:</strong> May be presenting sign, can be life-threatening</li>
                        <li><strong>Metabolic Acidosis:</strong> High anion gap from uremia</li>
                        <li><strong>Elderly:</strong> Minimal symptoms despite significant Cr elevation</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">Labs:</span> BMP (Cr, BUN, K+), baseline Cr for comparison, UA with microscopy, urine electrolytes (Na+, Cr, osmolality)</p>
                    <p><span class="label">Imaging:</span> Renal US (assess for obstruction, kidney size, hydronephrosis)</p>
                    <p><span class="label">Consider:</span> Renal biopsy if diagnosis unclear or concern for glomerulonephritis</p>
                    
                    <p><span class="label">Categorize AKI:</span></p>
                    <ul>
                        <li><strong>Prerenal (60-70%):</strong> Decreased renal perfusion - volume depletion, heart failure, cirrhosis, NSAIDs</li>
                        <li><strong>Intrinsic (25-40%):</strong> Acute tubular necrosis (ischemia, nephrotoxins), acute interstitial nephritis, glomerulonephritis</li>
                        <li><strong>Postrenal (5-10%):</strong> Obstruction - BPH, kidney stones, malignancy, neurogenic bladder</li>
                    </ul>
                    
                    <!-- FENa Calculator -->
                    <div id="calc-fena" class="calculator">
                        <div class="calculator-title">üßÆ FENa Calculator</div>
                        <div class="calc-description">
                            <strong>Use:</strong> Differentiate prerenal AKI (<1%) from ATN (>2%). FENa 1-2% is indeterminate. If on diuretics, use FEUrea instead.
                        </div>
                        
                        <div class="calc-item">
                            <label>Urine Sodium (mEq/L)
                                <span class="hint">From random urine sample</span>
                            </label>
                            <input type="number" id="fena-urine-na" placeholder="e.g., 20" min="0" step="1">
                        </div>
                        
                        <div class="calc-item">
                            <label>Serum Sodium (mEq/L)
                                <span class="hint">From BMP - typically 135-145</span>
                            </label>
                            <input type="number" id="fena-serum-na" placeholder="e.g., 140" min="100" max="180" value="140">
                        </div>
                        
                        <div class="calc-item">
                            <label>Urine Creatinine (mg/dL)
                                <span class="hint">From random urine sample</span>
                            </label>
                            <input type="number" id="fena-urine-cr" placeholder="e.g., 80" min="0" step="0.1">
                        </div>
                        
                        <div class="calc-item">
                            <label>Serum Creatinine (mg/dL)
                                <span class="hint">From BMP</span>
                            </label>
                            <input type="number" id="fena-serum-cr" placeholder="e.g., 2.5" min="0" step="0.1">
                        </div>
                        
                        <button class="calc-button" onclick="calculateFENa()">Calculate FENa</button>
                        <div id="fena-result"></div>
                    </div>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL</div>
                <div class="section-content">
                    <p><span class="label">General Principles:</span></p>
                    <ul>
                        <li>Treat underlying cause</li>
                        <li>Stop nephrotoxins (NSAIDs, ACE-I/ARB if AKI severe, aminoglycosides, contrast)</li>
                        <li>Adjust all medication doses for GFR</li>
                        <li>Avoid further insults (hypotension, contrast, nephrotoxic drugs)</li>
                    </ul>
                    
                    <p><span class="label">Prerenal AKI:</span></p>
                    <ul>
                        <li><strong>Volume Depletion:</strong> IV fluids (LR or NS), correct hypotension</li>
                        <li><strong>Cardiorenal:</strong> Diuresis if volume overloaded, optimize cardiac output</li>
                        <li><strong>Hepatorenal:</strong> Albumin + midodrine + octreotide, or terlipressin</li>
                    </ul>
                    
                    <p><span class="label">Intrinsic AKI:</span></p>
                    <ul>
                        <li><strong>ATN:</strong> Supportive care, avoid nephrotoxins, optimize hemodynamics. Usually resolves in 1-3 weeks</li>
                        <li><strong>AIN (Acute Interstitial Nephritis):</strong> Stop offending drug, consider steroids if severe/not improving</li>
                        <li><strong>Glomerulonephritis:</strong> Nephrology consult, may need steroids/immunosuppression ¬± plasmapheresis</li>
                    </ul>
                    
                    <p><span class="label">Postrenal AKI:</span></p>
                    <ul>
                        <li><strong>Relieve Obstruction:</strong> Foley catheter (if bladder outlet obstruction), nephrostomy tubes, ureteral stents</li>
                        <li>Watch for post-obstructive diuresis - may need aggressive fluid replacement</li>
                    </ul>
                    
                    <p><span class="label">Indications for Dialysis (AEIOU):</span></p>
                    <ul>
                        <li><strong>A</strong>cidosis - severe metabolic acidosis (pH <7.1) refractory to medical management</li>
                        <li><strong>E</strong>lectrolytes - hyperkalemia refractory to medical therapy</li>
                        <li><strong>I</strong>ngestions - toxic alcohols, lithium, salicylates</li>
                        <li><strong>O</strong>verload - volume overload refractory to diuretics, pulmonary edema</li>
                        <li><strong>U</strong>remia - uremic pericarditis, encephalopathy, bleeding</li>
                    </ul>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>FENa limitations:</strong> Not valid if on diuretics (falsely elevated), chronic kidney disease, or contrast nephropathy. Use FEUrea if on diuretics (prerenal <35%)</li>
                    <li><strong>BUN:Cr ratio:</strong> >20:1 suggests prerenal (BUN reabsorbed more than Cr). <15:1 suggests intrinsic renal disease</li>
                    <li><strong>Muddy brown casts:</strong> Pathognomonic for ATN on urine microscopy</li>
                    <li><strong>Triple whammy:</strong> ACE-I/ARB + diuretic + NSAID = high risk for AKI. Avoid this combination!</li>
                    <li><strong>Contrast-induced AKI:</strong> Peak Cr at 3-5 days. Prevent with IV fluids before/after contrast. No evidence for NAC or bicarb</li>
                    <li><strong>Post-obstructive diuresis:</strong> Can lose massive amounts of fluid after obstruction relieved. Replace half of UOP with 0.45% NS</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>Hyperkalemia >6.5 with ECG changes</li>
                        <li>Severe metabolic acidosis (pH <7.2)</li>
                        <li>Volume overload with respiratory failure</li>
                        <li>Uremic encephalopathy/pericarditis</li>
                        <li>Need for emergent dialysis</li>
                        <li>Hemodynamic instability</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>Cr downtrending or stable</li>
                        <li>No dialysis-requiring complications</li>
                        <li>Electrolytes controlled (K+ <5.5)</li>
                        <li>Volume status optimized</li>
                        <li>Cause identified and addressed</li>
                        <li>Nephrotoxins stopped</li>
                        <li>Close nephrology follow-up if Cr not at baseline</li>
                        <li>Patient educated on medication adjustments</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">COMPLICATIONS TO MONITOR</div>
                <div class="section-content">
                    <p><strong>Acute:</strong> Hyperkalemia, metabolic acidosis, volume overload, uremia, need for dialysis, death</p>
                    <p><strong>Chronic:</strong> Chronic kidney disease, progression to ESRD, recurrent AKI episodes</p>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 11: HYPERKALEMIA -->
        <div id="hyperkalemia" class="condition-page">
            <div class="page-header">
                <h2>11. HYPERKALEMIA</h2>
                <div class="subtitle">K+ >5.5 mEq/L ‚Ä¢ Life-Threatening Arrhythmias</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Classic:</span> Often asymptomatic until severe. Weakness, paresthesias, palpitations</p>
                    <p><span class="label">ECG Changes (Progressive):</span></p>
                    <ul>
                        <li><strong>Mild (5.5-6.5):</strong> Peaked T waves (tall, narrow, symmetric)</li>
                        <li><strong>Moderate (6.5-8):</strong> PR prolongation, P wave flattening/loss, QRS widening</li>
                        <li><strong>Severe (>8):</strong> Sine wave pattern, ventricular fibrillation, asystole</li>
                    </ul>
                    <p><span class="label">Alternate Presentations:</span></p>
                    <ul>
                        <li><strong>Pseudohyperkalemia:</strong> Hemolysis during blood draw, severe leukocytosis/thrombocytosis, fist clenching</li>
                        <li><strong>Acute on Chronic:</strong> Patients on ACE-I/ARB with CKD who take NSAIDs or get dehydrated</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">Labs:</span> Repeat K+ to confirm (rule out pseudohyperkalemia), BMP, Mg, Ca, VBG, consider digoxin level if on digoxin</p>
                    <p><span class="label">ECG:</span> CRITICAL - assess for cardiotoxicity. ECG changes indicate true emergency</p>
                    <p><span class="label">Identify Cause:</span></p>
                    <ul>
                        <li><strong>Increased Intake:</strong> K+ supplements, salt substitutes, IV K+</li>
                        <li><strong>Transcellular Shift:</strong> Acidosis, insulin deficiency, Œ≤-blocker, digoxin toxicity, succinylcholine, tumor lysis</li>
                        <li><strong>Decreased Excretion:</strong> AKI/CKD, hypoaldosteronism, ACE-I/ARB, K+-sparing diuretics, NSAIDs, heparin, TMP-SMX</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL (Sequence Matters!)</div>
                <div class="section-content">
                    <p><span class="label">Step 1: Cardiac Membrane Stabilization (if ECG changes or K >6.5):</span></p>
                    <ul>
                        <li><strong>Calcium Gluconate:</strong> 1-2 amps (10-20 mL of 10% solution) IV over 2-3 min</li>
                        <li>OR <strong>Calcium Chloride:</strong> 0.5-1g (5-10 mL of 10%) IV via central line (more potent, sclerosing)</li>
                        <li>Effect: Immediate (1-3 min), duration 30-60 min</li>
                        <li>Does NOT lower K+, only protects heart</li>
                        <li>Can repeat dose if persistent ECG changes</li>
                    </ul>
                    
                    <p><span class="label">Step 2: Shift K+ Intracellularly (Temporary):</span></p>
                    <ul>
                        <li><strong>Insulin + Dextrose:</strong> Regular insulin 10 units IV + D50 50mL (25g dextrose) IV push
                            <ul>
                                <li>If glucose >250: give insulin alone, no dextrose</li>
                                <li>Effect: 15-30 min, duration 4-6 hours</li>
                                <li>Lowers K+ by 0.5-1.5 mEq/L</li>
                                <li>Check glucose in 1hr (risk hypoglycemia)</li>
                            </ul>
                        </li>
                        <li><strong>Albuterol:</strong> 10-20mg nebulized (or 0.5mg IV)
                            <ul>
                                <li>Effect: 30 min, duration 2-4 hours</li>
                                <li>Lowers K+ by 0.5-1 mEq/L</li>
                                <li>Additive with insulin</li>
                            </ul>
                        </li>
                        <li><strong>Sodium Bicarbonate:</strong> 50-100 mEq (1-2 amps) IV over 5 min (only if concurrent metabolic acidosis)
                            <ul>
                                <li>Controversial efficacy if pH normal</li>
                            </ul>
                        </li>
                    </ul>
                    
                    <p><span class="label">Step 3: Remove K+ from Body (Definitive):</span></p>
                    <ul>
                        <li><strong>Loop Diuretic:</strong> Furosemide 40-80mg IV (if adequate renal function)</li>
                        <li><strong>Sodium Polystyrene Sulfonate (Kayexalate):</strong> 15-30g PO/PR
                            <ul>
                                <li>Effect: Hours, lowers K+ by 0.5-1 mEq/L</li>
                                <li>Avoid if ileus (risk colonic necrosis)</li>
                            </ul>
                        </li>
                        <li><strong>Patiromer or Sodium Zirconium:</strong> Newer K+ binders, better tolerated but slower onset</li>
                        <li><strong>Hemodialysis:</strong> Most effective. Indications:
                            <ul>
                                <li>K+ >6.5 with ECG changes refractory to medical management</li>
                                <li>Severe AKI/ESRD</li>
                                <li>Ongoing tissue breakdown (rhabdo, tumor lysis)</li>
                            </ul>
                        </li>
                    </ul>
                    
                    <p><span class="label">Step 4: Stop Exacerbating Factors:</span> Hold ACE-I/ARB, K+-sparing diuretics, NSAIDs, K+ supplements</p>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>ECG trumps K+ level:</strong> If ECG shows changes, treat aggressively regardless of exact K+ value. ECG changes = cardiac emergency!</li>
                    <li><strong>Calcium first!</strong> If ECG changes, give calcium before anything else. Protects heart immediately while you arrange other therapies</li>
                    <li><strong>Insulin hypoglycemia:</strong> Very common! Check glucose 30min and 1hr after insulin. Have D50 ready. Consider dextrose infusion</li>
                    <li><strong>Kayexalate controversy:</strong> Limited evidence for efficacy, risk of colonic necrosis esp with sorbitol. Consider newer agents</li>
                    <li><strong>Repeat K+ frequently:</strong> Check K+ q2-4h during acute management. Temporizing measures wear off!</li>
                    <li><strong>Chronic management:</strong> Low K+ diet, loop diuretics, K+ binders. Avoid "hyperkalemia cocktail" (ACE-I + spironolactone + NSAIDs)</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>K+ >6.5 with ECG changes</li>
                        <li>Hemodynamically significant arrhythmias</li>
                        <li>Need for emergent dialysis</li>
                        <li>Rapidly rising K+ despite treatment</li>
                        <li>Cardiac arrest from hyperkalemia</li>
                        <li>Requires continuous cardiac monitoring</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>K+ <5.5 mEq/L and downtrending</li>
                        <li>ECG normalized (no peaked T waves)</li>
                        <li>Cause identified and addressed</li>
                        <li>K+-raising medications stopped/adjusted</li>
                        <li>Patient educated on low K+ diet</li>
                        <li>Close follow-up with repeat K+ within 2-3 days</li>
                        <li>If CKD: nephrology follow-up arranged</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">COMPLICATIONS TO MONITOR</div>
                <div class="section-content">
                    <p><strong>Cardiac:</strong> Ventricular arrhythmias (VT, VF), heart block, asystole, sudden cardiac death</p>
                    <p><strong>From Treatment:</strong> Hypoglycemia (insulin), hypokalemia rebound, volume overload (from IVF), GI complications (kayexalate)</p>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 12: HYPONATREMIA -->
        <div id="hyponatremia" class="condition-page">
            <div class="page-header">
                <h2>12. HYPONATREMIA</h2>
                <div class="subtitle">Na+ <135 mEq/L ‚Ä¢ Osmotic Demyelination Risk</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Classic:</span> Nausea, headache, confusion, lethargy, seizures (if severe/acute)</p>
                    <p><span class="label">Severity by Symptoms:</span></p>
                    <ul>
                        <li><strong>Mild (Na 130-135):</strong> Often asymptomatic or mild nausea</li>
                        <li><strong>Moderate (125-129):</strong> Nausea, confusion, headache</li>
                        <li><strong>Severe (<125):</strong> Vomiting, seizures, coma, respiratory arrest</li>
                    </ul>
                    <p><span class="label">Alternate Presentations:</span></p>
                    <ul>
                        <li><strong>Elderly:</strong> Falls, gait instability, cognitive impairment</li>
                        <li><strong>Athletes:</strong> Exercise-associated hyponatremia from excessive free water intake</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">Step 1 - Check Serum Osmolality:</span></p>
                    <ul>
                        <li><strong>Isotonic (280-295):</strong> Pseudohyponatremia (hyperglycemia, hyperlipidemia, hyperproteinemia)</li>
                        <li><strong>Hypertonic (>295):</strong> Hyperglycemia, mannitol</li>
                        <li><strong>Hypotonic (<280):</strong> True hyponatremia - proceed to step 2</li>
                    </ul>
                    
                    <p><span class="label">Step 2 - Assess Volume Status:</span></p>
                    <ul>
                        <li><strong>Hypovolemic:</strong> Dry mucous membranes, ‚Üìskin turgor, orthostatic hypotension
                            <ul>
                                <li>Urine Na <20: GI losses, third-spacing, skin losses</li>
                                <li>Urine Na >40: Diuretics, salt-wasting nephropathy, adrenal insufficiency</li>
                            </ul>
                        </li>
                        <li><strong>Euvolemic:</strong> Normal volume status
                            <ul>
                                <li>SIADH (most common), hypothyroidism, adrenal insufficiency, psychogenic polydipsia</li>
                            </ul>
                        </li>
                        <li><strong>Hypervolemic:</strong> Edema, elevated JVP, ascites
                            <ul>
                                <li>CHF, cirrhosis, nephrotic syndrome, advanced CKD</li>
                            </ul>
                        </li>
                    </ul>
                    
                    <p><span class="label">Labs:</span> Serum osmolality, urine osmolality, urine Na, BMP, TSH, cortisol if indicated</p>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL</div>
                <div class="section-content">
                    <p><span class="label">‚ö†Ô∏è CRITICAL:</span> Correct slowly! Maximum 8-10 mEq/L in first 24 hours. Faster correction ‚Üí osmotic demyelination syndrome</p>
                    
                    <p><span class="label">Acute Symptomatic (<48hr onset with seizures/coma):</span></p>
                    <ul>
                        <li><strong>3% Hypertonic Saline:</strong> 100 mL IV bolus over 10 min, can repeat √ó 2 if needed</li>
                        <li>Goal: Raise Na by 4-6 mEq/L (enough to stop seizures), then slow correction</li>
                        <li>Check Na q2-4h</li>
                    </ul>
                    
                    <p><span class="label">Chronic or Asymptomatic:</span></p>
                    <ul>
                        <li><strong>Hypovolemic:</strong> NS at 0.5-1 mL/kg/hr. Na will auto-correct with volume repletion</li>
                        <li><strong>Euvolemic (SIADH):</strong> 
                            <ul>
                                <li>Fluid restriction (800-1000 mL/day)</li>
                                <li>Treat underlying cause</li>
                                <li>Salt tabs + loop diuretic if needed</li>
                                <li>Tolvaptan (vasopressin antagonist) for refractory cases</li>
                            </ul>
                        </li>
                        <li><strong>Hypervolemic:</strong> Fluid + sodium restriction, diuretics, treat underlying (CHF, cirrhosis)</li>
                    </ul>
                    
                    <p><span class="label">Correction Rate Calculation:</span></p>
                    <ul>
                        <li>Target: 6-8 mEq/L in 24 hours, 12-14 mEq/L in 48 hours</li>
                        <li>High-risk patients (chronic, malnourished, cirrhosis, K+ <3): Limit to 6 mEq/L in 24hr</li>
                    </ul>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>Osmotic demyelination (ODS):</strong> From overly rapid correction. Presents 2-6 days later with dysarthria, dysphagia, quadriplegia, locked-in syndrome. PREVENT by slow correction!</li>
                    <li><strong>SIADH criteria:</strong> Hyponatremia + low serum osm (<280) + inappropriately concentrated urine (>100) + euvolemic + normal thyroid/adrenal</li>
                    <li><strong>Beer potomania:</strong> Hyponatremia from excessive beer intake with poor solute intake. Na can rise dangerously fast when solute repleted!</li>
                    <li><strong>Tea and toast diet:</strong> Similar to beer potomania - inadequate solute intake in elderly</li>
                    <li><strong>Exercise-associated:</strong> From drinking too much water during endurance events. Treat with hypertonic saline, NOT more water!</li>
                    <li><strong>Hyperglycemia correction:</strong> For every 100 mg/dL glucose >100, add 1.6 mEq/L to measured Na to get "true" Na</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>Seizures or coma</li>
                        <li>Na <120 mEq/L</li>
                        <li>Acute symptomatic hyponatremia</li>
                        <li>Need for 3% hypertonic saline</li>
                        <li>Rapid changes requiring q2h monitoring</li>
                        <li>Respiratory compromise</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>Na >125 mEq/L and stable/improving</li>
                        <li>Asymptomatic or symptoms resolved</li>
                        <li>Underlying cause identified/treated</li>
                        <li>Can comply with fluid restriction if needed</li>
                        <li>Follow-up arranged with Na check in 2-3 days</li>
                        <li>Patient educated on risks</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">COMPLICATIONS TO MONITOR</div>
                <div class="section-content">
                    <p><strong>From Hyponatremia:</strong> Seizures, cerebral edema, respiratory arrest, death</p>
                    <p><strong>From Overcorrection:</strong> Osmotic demyelination syndrome (irreversible neurologic damage)</p>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 13: DIABETIC KETOACIDOSIS -->
        <div id="dka" class="condition-page">
            <div class="page-header">
                <h2>13. DIABETIC KETOACIDOSIS (DKA)</h2>
                <div class="subtitle">Hyperglycemia ‚Ä¢ Acidosis ‚Ä¢ Ketones</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Classic Triad:</span> (1) Hyperglycemia (>250), (2) Anion gap metabolic acidosis, (3) Ketones</p>
                    <p><span class="label">Classic Symptoms:</span> Polyuria, polydipsia, N/V, abdominal pain, Kussmaul respirations (deep, rapid), fruity breath odor, altered mental status</p>
                    <p><span class="label">Precipitants (5 I's):</span></p>
                    <ul>
                        <li><strong>Infection:</strong> Most common (UTI, pneumonia, etc)</li>
                        <li><strong>Insulin:</strong> Non-compliance or inadequate dosing</li>
                        <li><strong>Ischemia:</strong> MI, stroke</li>
                        <li><strong>Intoxication:</strong> Alcohol, drugs</li>
                        <li><strong>Infant:</strong> Pregnancy</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">DKA Criteria:</span></p>
                    <ul>
                        <li>Glucose >250 mg/dL (or known diabetic)</li>
                        <li>pH <7.3 (arterial) or HCO3 <18</li>
                        <li>Anion gap >10</li>
                        <li>Positive serum/urine ketones</li>
                    </ul>
                    
                    <p><span class="label">Labs:</span> VBG (pH, HCO3), BMP, anion gap, Œ≤-hydroxybutyrate (preferred over urine ketones), phosphate, Mg, CBC, blood cultures, UA/CXR if infection suspected</p>
                    <p><span class="label">Calculate:</span> Anion gap = Na - (Cl + HCO3). Normal 8-12. Also calculate osmolality if altered mental status</p>
                    <p><span class="label">Severity:</span></p>
                    <ul>
                        <li><strong>Mild:</strong> pH 7.25-7.30, HCO3 15-18</li>
                        <li><strong>Moderate:</strong> pH 7.0-7.24, HCO3 10-14</li>
                        <li><strong>Severe:</strong> pH <7.0, HCO3 <10</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL</div>
                <div class="section-content">
                    <p><span class="label">1. Fluids (MOST IMPORTANT):</span></p>
                    <ul>
                        <li><strong>Initial:</strong> NS 1-1.5 L over first hour (15-20 mL/kg/hr)</li>
                        <li><strong>Subsequent:</strong> 
                            <ul>
                                <li>If Na normal/high: 0.45% NS at 250-500 mL/hr</li>
                                <li>If Na low: NS at 250-500 mL/hr</li>
                            </ul>
                        </li>
                        <li><strong>Once glucose <250:</strong> Switch to D5 0.45% NS to prevent hypoglycemia while continuing insulin</li>
                        <li>Total deficit usually 5-10 L - replace over 24-48 hours</li>
                    </ul>
                    
                    <p><span class="label">2. Insulin:</span></p>
                    <ul>
                        <li><strong>Regular insulin IV infusion:</strong> 0.1 units/kg/hr (usually 5-10 units/hr)</li>
                        <li>Optional bolus: 0.1 units/kg IV if severe DKA</li>
                        <li>Goal: Decrease glucose by 50-75 mg/dL/hr</li>
                        <li><strong>Do NOT stop insulin</strong> when glucose reaches 250! Switch to D5-containing fluids and continue insulin until anion gap closes</li>
                        <li>Once anion gap closed: Transition to subQ insulin, overlap by 1-2 hours before stopping gtt</li>
                    </ul>
                    
                    <p><span class="label">3. Potassium Repletion (CRITICAL):</span></p>
                    <ul>
                        <li><strong>If K+ <3.3:</strong> Hold insulin, give K+ 20-30 mEq/hr until K >3.3</li>
                        <li><strong>If K+ 3.3-5.2:</strong> Add 20-30 mEq K+ to each liter of fluids</li>
                        <li><strong>If K+ >5.2:</strong> No K+ initially, check q2-4h (will drop with insulin)</li>
                        <li>Goal: K+ 4-5 mEq/L</li>
                    </ul>
                    
                    <p><span class="label">4. Phosphate (if <1.0 mg/dL):</span> K-phos 20-30 mEq/L in fluids</p>
                    
                    <p><span class="label">5. Bicarbonate (controversial, only if pH <6.9):</span> 100 mEq in 400 mL H2O + 20 mEq KCl over 2 hours</p>
                    
                    <p><span class="label">6. Treat Precipitant:</span> Antibiotics if infection, adjust insulin regimen, etc</p>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>DKA resolution:</strong> Glucose <200 AND anion gap <12 AND HCO3 >18 AND pH >7.3. Don't stop insulin just because glucose normalized!</li>
                    <li><strong>Two-bag system:</strong> Run two IV bags (one NS, one D5-NS) through Y-connector. Adjust ratio to maintain glucose 150-200 while continuing insulin</li>
                    <li><strong>Euglycemic DKA:</strong> Can occur with SGLT2 inhibitors. Check ketones even if glucose <250!</li>
                    <li><strong>K+ shifts:</strong> Total body K+ depleted despite normal/high initial K+. With insulin, K+ shifts into cells ‚Üí life-threatening hypokalemia. Monitor closely!</li>
                    <li><strong>Cerebral edema:</strong> Rare but fatal. More common in kids. From too-rapid correction. Symptoms: Headache, AMS, bradycardia. Give mannitol/3% saline</li>
                    <li><strong>Anion gap:</strong> Closes before ketones clear. Don't discharge until ketones clearing and patient eating</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>pH <7.0</li>
                        <li>HCO3 <10</li>
                        <li>Altered mental status</li>
                        <li>Hemodynamic instability</li>
                        <li>Need for continuous insulin infusion</li>
                        <li>Severe electrolyte derangements</li>
                        <li>Cerebral edema concern</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>DKA resolved (AG <12, HCO3 >18, pH >7.3)</li>
                        <li>Tolerating PO intake</li>
                        <li>Transitioned to subQ insulin</li>
                        <li>Ketones clearing</li>
                        <li>Precipitant identified and treated</li>
                        <li>Patient educated on sick day management</li>
                        <li>Diabetes follow-up arranged</li>
                        <li>No ongoing complications</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">COMPLICATIONS TO MONITOR</div>
                <div class="section-content">
                    <p><strong>Acute:</strong> Cerebral edema (1%), hypokalemia, hypoglycemia, ARDS, thrombosis, mucormycosis</p>
                    <p><strong>From Treatment:</strong> Hyperchloremic non-gap acidosis (from NS), volume overload</p>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 14: HYPEROSMOLAR HYPERGLYCEMIC STATE -->
        <div id="hhs" class="condition-page">
            <div class="page-header">
                <h2>14. HYPEROSMOLAR HYPERGLYCEMIC STATE (HHS)</h2>
                <div class="subtitle">Extreme Hyperglycemia ‚Ä¢ Hyperosmolarity ‚Ä¢ Type 2 DM</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Key Differences from DKA:</span> More extreme hyperglycemia (>600), higher osmolality (>320), NO significant ketoacidosis, more profound dehydration</p>
                    <p><span class="label">Classic:</span> Altered mental status, severe dehydration, hypotension. Often insidious onset over days-weeks</p>
                    <p><span class="label">Typical Patient:</span> Elderly Type 2 diabetic with infection or medication non-compliance</p>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">HHS Criteria:</span></p>
                    <ul>
                        <li>Glucose >600 mg/dL</li>
                        <li>Effective serum osmolality >320 mOsm/kg</li>
                        <li>pH >7.30</li>
                        <li>HCO3 >15</li>
                        <li>Minimal ketones (can have trace)</li>
                    </ul>
                    <p><span class="label">Calculate Osmolality:</span> 2(Na) + glucose/18 + BUN/2.8. Normal 280-295</p>
                    <p><span class="label">Labs:</span> Same as DKA - VBG, BMP, identify precipitant</p>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL</div>
                <div class="section-content">
                    <p><span class="label">1. Aggressive Fluid Resuscitation (MORE than DKA):</span></p>
                    <ul>
                        <li>Initial: NS 1-1.5 L first hour</li>
                        <li>Subsequent: 250-500 mL/hr based on volume status</li>
                        <li>Total deficit often 8-12 L (more than DKA)</li>
                        <li>Goal: Replace half of deficit in first 12-24 hours</li>
                    </ul>
                    
                    <p><span class="label">2. Insulin (LOWER rates than DKA):</span></p>
                    <ul>
                        <li>Wait 1-2 hours, give fluids first to avoid vascular collapse</li>
                        <li>Then start insulin 0.05-0.1 units/kg/hr (lower than DKA)</li>
                        <li>Goal: Decrease glucose by 50-75 mg/dL/hr</li>
                        <li>Once glucose <300: Add dextrose to fluids, continue insulin</li>
                    </ul>
                    
                    <p><span class="label">3. Potassium:</span> Same principles as DKA</p>
                    
                    <p><span class="label">4. Correct Slowly:</span> Osmolality should decrease by <3 mOsm/kg/hr to avoid cerebral edema</p>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>HHS vs DKA:</strong> HHS = Type 2 DM, more dehydration, higher glucose (>600), no ketosis. DKA = Type 1, ketoacidosis</li>
                    <li><strong>Why no ketosis?</strong> Type 2 patients have enough insulin to prevent lipolysis but not enough to control glucose</li>
                    <li><strong>Mortality higher:</strong> HHS mortality 10-20% (vs 1-5% for DKA) - sicker, older patients</li>
                    <li><strong>Fluids first!</strong> Give 1-2 L NS before starting insulin to prevent cardiovascular collapse</li>
                    <li><strong>Slower correction:</strong> Osmolality built up over longer time, correct more slowly to avoid cerebral edema</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>Altered mental status/coma</li>
                        <li>Osmolality >350</li>
                        <li>Hemodynamic instability</li>
                        <li>Need for insulin infusion</li>
                        <li>Severe electrolyte abnormalities</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>Glucose <250 and stable</li>
                        <li>Mental status at baseline</li>
                        <li>Osmolality <310</li>
                        <li>Taking PO</li>
                        <li>On appropriate diabetes regimen</li>
                        <li>Precipitant treated</li>
                    </ul>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- PAGE 15: UPPER GI BLEED -->
        <div id="ugib" class="condition-page">
            <div class="page-header">
                <h2>15. UPPER GI BLEED</h2>
                <div class="subtitle">Hematemesis ‚Ä¢ Melena ‚Ä¢ Variceal vs Non-Variceal</div>
            </div>
            
            <div class="section">
                <div class="section-title">CLINICAL PRESENTATION</div>
                <div class="section-content">
                    <p><span class="label">Classic:</span> Hematemesis (bright red or coffee-ground), melena (black tarry stool), syncope, hemodynamic instability</p>
                    <p><span class="label">Common Causes:</span></p>
                    <ul>
                        <li><strong>Non-Variceal (90%):</strong> PUD (H. pylori, NSAIDs), erosive gastritis/esophagitis, Mallory-Weiss tear, Dieulafoy lesion</li>
                        <li><strong>Variceal (10%):</strong> Esophageal or gastric varices (cirrhosis, portal hypertension)</li>
                    </ul>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">DIAGNOSTIC WORKUP</div>
                <div class="section-content">
                    <p><span class="label">Immediate:</span> Two large-bore IVs, CBC, type & cross (4 units), BMP, coags, LFTs</p>
                    <p><span class="label">Risk Stratification:</span> Glasgow-Blatchford Score (score 0 = safe for outpatient, ‚â•1 consider admission)</p>
                    <p><span class="label">EGD:</span> Within 24 hours (within 12 hours if high risk/variceal suspected)</p>
                </div>
            </div>
            
            <div class="section">
                <div class="section-title">TREATMENT PROTOCOL</div>
                <div class="section-content">
                    <p><span class="label">Resuscitation:</span></p>
                    <ul>
                        <li><strong>Transfusion:</strong> Goal Hgb 7-9 (restrictive strategy). Higher target (9-10) if active cardiac disease</li>
                        <li><strong>Fluids:</strong> Crystalloids for volume resuscitation</li>
                        <li><strong>Correct coagulopathy:</strong> Reverse anticoagulation if active bleeding, give FFP/PCC if INR >1.8</li>
                    </ul>
                    
                    <p><span class="label">Pharmacotherapy:</span></p>
                    <ul>
                        <li><strong>PPI:</strong> Pantoprazole 80mg IV bolus, then 8mg/hr infusion √ó 72hr (for non-variceal)</li>
                        <li><strong>If Variceal Suspected:</strong> Octreotide 50 mcg bolus, then 50 mcg/hr infusion</li>
                        <li><strong>Antibiotics (if cirrhotic):</strong> Ceftriaxone 1g IV daily √ó 7 days (reduces mortality)</li>
                    </ul>
                    
                    <p><span class="label">Endoscopic Management:</span></p>
                    <ul>
                        <li><strong>PUD:</strong> Epinephrine injection + thermal coagulation ¬± clips</li>
                        <li><strong>Varices:</strong> Band ligation (preferred) or sclerotherapy</li>
                        <li><strong>If refractory variceal bleeding:</strong> Balloon tamponade (Blakemore tube), TIPS</li>
                    </ul>
                </div>
            </div>
            
            <div class="pearl-box">
                <div class="pearl-title">üîë TEACHING PEARLS</div>
                <ul>
                    <li><strong>Don't over-transfuse:</strong> Target Hgb 7-9. Higher targets worsen outcomes (increased rebleeding)</li>
                    <li><strong>Rockall score:</strong> Post-EGD risk score. Predicts rebleeding and mortality</li>
                    <li><strong>PPI timing:</strong> Pre-EGD PPI doesn't reduce mortality but may reduce stigmata of recent hemorrhage</li>
                    <li><strong>Mallory-Weiss:</strong> Longitudinal tear at GE junction from forceful vomiting. Usually self-limited</li>
                    <li><strong>NG tube controversial:</strong> Not routinely needed. Doesn't improve outcomes, uncomfortable for patient</li>
                </ul>
            </div>
            
            <div class="two-column">
                <div class="box">
                    <div class="box-title">‚ö†Ô∏è ESCALATE TO ICU IF:</div>
                    <ul>
                        <li>Hemodynamic instability despite resuscitation</li>
                        <li>Massive transfusion (>4 units in 24hr)</li>
                        <li>Variceal bleeding</li>
                        <li>Rebleeding after endoscopic intervention</li>
                        <li>Need for airway protection</li>
                    </ul>
                </div>
                
                <div class="box">
                    <div class="box-title">‚úì DISCHARGE CRITERIA</div>
                    <ul>
                        <li>Hemodynamically stable √ó 24hr</li>
                        <li>Hgb stable (no transfusion need)</li>
                        <li>Post-EGD with low-risk lesion</li>
                        <li>Tolerating PO</li>
                        <li>On PPI BID √ó 2 weeks, then daily</li>
                        <li>H. pylori testing sent/treated</li>
                        <li>GI follow-up arranged</li>
                    </ul>
                </div>
            </div>
            
            <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
        </div>

        <!-- Continuing with remaining conditions... PAGE 16-20 -->
        <div class="condition-page" style="background: #f6f8fa; text-align: center; padding: 60px 30px;">
<!-- CONDITIONS 16-40 COMPLETE -->

<div id="cirrhosis" class="condition-page">
    <div class="page-header"><h2>16. CIRRHOSIS WITH ASCITES</h2><div class="subtitle">Portal Hypertension ‚Ä¢ Decompensation</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Diagnosis:</strong> SAAG >1.1 indicates portal hypertension. Diagnostic paracentesis: cell count, albumin, protein, culture</p>
        <p><strong>Treatment:</strong> Sodium restriction <2g/day. Diuretics: Spironolactone 100mg + Furosemide 40mg (maintain 100:40 ratio). Large volume paracentesis if tense with albumin 6-8g per liter removed. Monitor for SBP</p>
        <p><strong>Complications:</strong> SBP, hepatorenal syndrome, hepatic hydrothorax</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="sbp" class="condition-page">
    <div class="page-header"><h2>17. SPONTANEOUS BACTERIAL PERITONITIS (SBP)</h2><div class="subtitle">Infected Ascites</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Diagnosis:</strong> PMN >250 cells/mm¬≥ in ascitic fluid. Culture positive in 50%</p>
        <p><strong>Treatment:</strong> Ceftriaxone 2g IV daily √ó 5-7 days. Albumin 1.5g/kg day 1, then 1g/kg day 3 (reduces mortality/HRS). Secondary prophylaxis: Norfloxacin 400mg daily or Cipro 750mg weekly</p>
        <p><strong>Pearl:</strong> Start empiric treatment if PMN >250 even if culture negative</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="he" class="condition-page">
    <div class="page-header"><h2>18. HEPATIC ENCEPHALOPATHY</h2><div class="subtitle">Altered Mental Status in Cirrhosis</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Grading:</strong> Grade 1 (confusion), Grade 2 (drowsy), Grade 3 (stuporous), Grade 4 (coma). Look for asterixis</p>
        <p><strong>Precipitants:</strong> GI bleed, infection, constipation, electrolyte abnormalities, medications (benzos, opioids)</p>
        <p><strong>Treatment:</strong> Lactulose 30mL PO q2-4h until 2-3 BMs/day. Rifaximin 550mg BID added if recurrent. Treat precipitant. Zinc 220mg daily if deficient</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="pancreatitis" class="condition-page">
    <div class="page-header"><h2>19. ACUTE PANCREATITIS</h2><div class="subtitle">Gallstones ‚Ä¢ Alcohol ‚Ä¢ Hypertriglyceridemia</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Diagnosis:</strong> 2 of 3: (1) Epigastric pain radiating to back, (2) Lipase >3√ó ULN, (3) Imaging findings. Ranson's criteria or BISAP score for severity</p>
        <p><strong>Treatment:</strong> Aggressive IVF resuscitation (LR preferred, 250-500 mL/hr). Early oral feeding when tolerated (within 24hr if mild). Pain control. ERCP within 24hr if biliary obstruction/cholangitis. Antibiotics only if infected necrosis</p>
        <p><strong>Complications:</strong> Pancreatic necrosis, pseudocyst, splenic vein thrombosis, DM</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="cellulitis" class="condition-page">
    <div class="page-header"><h2>20. CELLULITIS</h2><div class="subtitle">Skin/Soft Tissue Infection</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Diagnosis:</strong> Erythema, warmth, edema, tenderness. Usually unilateral lower extremity. Check for lymphangitic streaking</p>
        <p><strong>Treatment:</strong> Cephalexin 500mg QID or Cefazolin 1-2g IV q8h (covers Strep, Staph). If purulent/abscess: add MRSA coverage (Vancomycin 15-20mg/kg q8-12h or Doxycycline 100mg BID). Duration 5-10 days</p>
        <p><strong>Pearl:</strong> Mark borders with pen to track progression. Elevation and analgesia important</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="uti" class="condition-page">
    <div class="page-header"><h2>21. URINARY TRACT INFECTION / PYELONEPHRITIS</h2><div class="subtitle">Cystitis ‚Ä¢ Pyelo</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Cystitis:</strong> Dysuria, frequency, hematuria. UA with pyuria. Rx: Nitrofurantoin 100mg BID √ó 5d or TMP-SMX DS BID √ó 3d (if local resistance <20%)</p>
        <p><strong>Pyelonephritis:</strong> Fever, flank pain, CVA tenderness, N/V. Rx: Ceftriaxone 1-2g IV daily or Fluoroquinolone. Duration 7-14 days</p>
        <p><strong>Complicated UTI:</strong> Men, pregnancy, immunosuppressed, abnormal anatomy, catheter. Needs longer treatment and imaging</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="cdiff" class="condition-page">
    <div class="page-header"><h2>22. CLOSTRIDIOIDES DIFFICILE INFECTION</h2><div class="subtitle">Antibiotic-Associated Diarrhea</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Diagnosis:</strong> ‚â•3 unformed stools/24hr + positive PCR or toxin. Leukocytosis common</p>
        <p><strong>Treatment:</strong> Vancomycin 125mg PO QID √ó 10 days (first-line) or Fidaxomicin 200mg BID √ó 10d. If severe (WBC >15k, Cr >1.5√ó): Vanc 125-500mg PO QID. If ileus/megacolon: add Vanc enema + IV Metronidazole 500mg q8h</p>
        <p><strong>Recurrence:</strong> First recurrence: repeat vanc. Second recurrence: consider fidaxomicin or vanc taper, then FMT</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="dvt" class="condition-page">
    <div class="page-header"><h2>23. DEEP VEIN THROMBOSIS (DVT)</h2><div class="subtitle">VTE ‚Ä¢ Anticoagulation</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Diagnosis:</strong> Wells score. Compression US (lack of vein compressibility). D-dimer if low probability</p>
        <p><strong>Treatment:</strong> Anticoagulation √ó 3 months (provoked) to indefinite (unprovoked/cancer). Options: Rivaroxaban 15mg BID √ó 21d then 20mg daily, Apixaban 10mg BID √ó 7d then 5mg BID, or LMWH bridge to warfarin (INR 2-3). IVC filter only if anticoagulation contraindicated</p>
        <p><strong>Complications:</strong> PE, post-thrombotic syndrome, phlegmasia cerulea dolens</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="stroke" class="condition-page">
    <div class="page-header"><h2>24. ACUTE ISCHEMIC STROKE</h2><div class="subtitle">CVA ‚Ä¢ tPA ‚Ä¢ Thrombectomy</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Diagnosis:</strong> NIHSS score. STAT CT head (r/o hemorrhage). CT angiography if large vessel occlusion suspected</p>
        <p><strong>Treatment:</strong> tPA (alteplase 0.9mg/kg, 10% bolus then 90% over 60min) if <4.5hr from onset and no contraindications. Mechanical thrombectomy if large vessel occlusion <24hr. ASA 325mg after 24hr if given tPA (immediately if no tPA). Admit to stroke unit</p>
        <p><strong>BP Management:</strong> Permissive HTN! Allow SBP <220 mmHg (or <185 if giving tPA)</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="seizure" class="condition-page">
    <div class="page-header"><h2>25. SEIZURE / STATUS EPILEPTICUS</h2><div class="subtitle">Convulsive ‚Ä¢ Non-Convulsive</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Status Epilepticus:</strong> Seizure >5 min or recurrent without return to baseline. Medical emergency!</p>
        <p><strong>Treatment:</strong> (1) Benzos: Lorazepam 4mg IV or Midazolam 10mg IM, repeat once. (2) Fosphenytoin 20 PE/kg IV or Levetiracetam 60mg/kg (max 4500mg) or Valproate 40mg/kg. (3) If refractory: Propofol/midazolam gtt, intubate. Identify cause: imaging, labs, LP if indicated</p>
        <p><strong>Workup:</strong> Glucose, lytes, tox screen, AED levels if applicable, CT/MRI, EEG, LP if febrile/immunocompromised</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="meningitis" class="condition-page">
    <div class="page-header"><h2>26. BACTERIAL MENINGITIS</h2><div class="subtitle">LP ‚Ä¢ Empiric Antibiotics</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Presentation:</strong> Fever, headache, neck stiffness, altered mental status. Kernig/Brudzinski signs. Rash if meningococcal</p>
        <p><strong>Treatment:</strong> DO NOT DELAY ANTIBIOTICS for LP! Give within 30min if suspected. Vancomycin 15-20mg/kg q8-12h + Ceftriaxone 2g q12h. Add Ampicillin 2g q4h if >50yo or immunosuppressed (Listeria). Dexamethasone 10mg IV q6h √ó 4 days (give before/with first abx dose)</p>
        <p><strong>LP:</strong> Opening pressure, cell count/diff, glucose, protein, Gram stain, culture. CSF glucose <40 or <50% serum glucose suggests bacterial</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="anemia" class="condition-page">
    <div class="page-header"><h2>27. ANEMIA</h2><div class="subtitle">Microcytic ‚Ä¢ Normocytic ‚Ä¢ Macrocytic</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Workup:</strong> CBC with MCV, reticulocyte count, iron studies, B12/folate. Peripheral smear</p>
        <p><strong>Microcytic (MCV <80):</strong> Iron deficiency (most common), thalassemia, anemia of chronic disease, sideroblastic</p>
        <p><strong>Normocytic (80-100):</strong> Acute blood loss, hemolysis, anemia of chronic disease, CKD, bone marrow failure</p>
        <p><strong>Macrocytic (>100):</strong> B12/folate deficiency, alcohol, hypothyroidism, myelodysplasia, medications</p>
        <p><strong>Transfusion:</strong> Threshold Hgb <7 g/dL (or <8 if CAD, <10 if acute MI). Symptom-directed if chronic</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="neutropenic-fever" class="condition-page">
    <div class="page-header"><h2>28. NEUTROPENIC FEVER</h2><div class="subtitle">ANC <500 ‚Ä¢ Oncologic Emergency</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Definition:</strong> Fever ‚â•38.3¬∞C or ‚â•38¬∞C for >1hr with ANC <500 or expected to decline <500</p>
        <p><strong>Treatment:</strong> Cefepime 2g IV q8h (or pip-tazo) within 1 hour. Add vancomycin if: catheter infection, severe mucositis, hypotension, or known MRSA. Add antifungal (micafungin) if fever persists >4-7 days despite abx. GCSF if high-risk MASCC score <21</p>
        <p><strong>Workup:</strong> Blood cultures √ó 2 (peripheral + central line if present), CBC, CMP, CXR, UA/culture</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="etoh-withdrawal" class="condition-page">
    <div class="page-header"><h2>29. ALCOHOL WITHDRAWAL</h2><div class="subtitle">CIWA-Ar ‚Ä¢ Delirium Tremens</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Timeline:</strong> Minor (6-12hr): tremor, anxiety, N/V. Seizures (12-48hr). DTs (48-72hr): severe autonomic instability, hallucinations</p>
        <p><strong>Treatment:</strong> CIWA-Ar protocol. Lorazepam 2-4mg IV/PO q1h prn CIWA >8 (or Diazepam 10-20mg). Thiamine 100mg IV daily √ó 3-5d (before glucose!), Folate 1mg daily, Multivitamin. Banana bag (thiamine, folate, magnesium)</p>
        <p><strong>Repletion:</strong> Magnesium 2-4g IV, Phosphate repletion, K+ as needed</p>
        <p><strong>DTs:</strong> ICU, high-dose benzos (may need phenobarbital if refractory), dexmedetomidine adjunct</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="delirium" class="condition-page">
    <div class="page-header"><h2>30. DELIRIUM</h2><div class="subtitle">Acute Confusional State</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Diagnosis:</strong> CAM criteria. Acute onset, fluctuating course, inattention, disorganized thinking OR altered consciousness</p>
        <p><strong>Causes:</strong> Infections, medications (anticholinergics, benzos, opioids), metabolic, hypoxia, stroke, intoxication/withdrawal</p>
        <p><strong>Treatment:</strong> Identify and treat underlying cause. Non-pharm: Reorient, sleep hygiene, early mobilization, avoid restraints, family presence. Minimize deliriogenic meds. Antipsychotics (haloperidol 0.5-2mg) only if severe agitation and danger to self/others</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="hyperthyroid" class="condition-page">
    <div class="page-header"><h2>31. HYPERTHYROIDISM / THYROID STORM</h2><div class="subtitle">Graves ‚Ä¢ Toxic Adenoma</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Presentation:</strong> Weight loss, tremor, palpitations, heat intolerance, diarrhea. Storm: Fever >40¬∞C, tachycardia, AMS, heart failure</p>
        <p><strong>Labs:</strong> TSH suppressed, Free T4/T3 elevated. TSI/TRAb positive in Graves</p>
        <p><strong>Treatment:</strong> (1) Œ≤-blocker: Propranolol 60-80mg q4-6h (also blocks T4‚ÜíT3 conversion). (2) Thionamide: PTU 600mg load then 200mg q6h OR Methimazole 20mg q6h. (3) Iodine solution 1 hour after thionamide (5 drops SSKI q6h). (4) Hydrocortisone 100mg q8h. (5) Cooling, IVF</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="hypothyroid" class="condition-page">
    <div class="page-header"><h2>32. HYPOTHYROIDISM / MYXEDEMA COMA</h2><div class="subtitle">Severe Hypothyroidism</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Presentation:</strong> Fatigue, weight gain, cold intolerance, constipation, bradycardia. Coma: hypothermia, hypoventilation, hyponatremia, AMS</p>
        <p><strong>Treatment:</strong> Outpatient: Levothyroxine 1.6 mcg/kg/day PO (start lower 25-50 mcg if elderly/CAD). Myxedema coma: T4 200-400 mcg IV load then 100 mcg IV daily + T3 10 mcg IV q8h. Hydrocortisone 100mg IV q8h (until adrenal insufficiency ruled out). Warming, ventilatory support, hypertonic saline for hyponatremia</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="adrenal" class="condition-page">
    <div class="page-header"><h2>33. ADRENAL INSUFFICIENCY / CRISIS</h2><div class="subtitle">Primary ‚Ä¢ Secondary</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Presentation:</strong> Hypotension, hyponatremia, hyperkalemia (primary only), hypoglycemia, abdominal pain. Crisis: shock, fever, AMS</p>
        <p><strong>Diagnosis:</strong> Morning cortisol <3 mcg/dL or cosyntropin stim test (cortisol <18-20 mcg/dL at 60min)</p>
        <p><strong>Treatment:</strong> Crisis: Hydrocortisone 100mg IV bolus, then 50-100mg IV q6-8h (or continuous 200mg/24hr) + aggressive IVF (NS 1-2L rapidly). Don't wait for testing - treat immediately if suspected! Chronic: Hydrocortisone 15-25mg/day divided BID-TID. Fludrocortisone 0.1mg daily if primary</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="hypercalcemia" class="condition-page">
    <div class="page-header"><h2>34. HYPERCALCEMIA</h2><div class="subtitle">Ca >10.5 mg/dL ‚Ä¢ Malignancy ‚Ä¢ Hyperparathyroidism</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Symptoms:</strong> "Stones, bones, groans, psychiatric overtones." Polyuria, constipation, weakness, confusion, short QT</p>
        <p><strong>Causes:</strong> Primary hyperparathyroidism (outpatient), malignancy (inpatient), granulomatous disease, meds (thiazides, lithium)</p>
        <p><strong>Treatment:</strong> (1) IV fluids: NS 200-300 mL/hr (rehydrate first!). (2) Calcitonin 4 units/kg subQ/IM q12h (rapid but tachyphylaxis). (3) Bisphosphonates: Pamidronate 60-90mg IV or Zoledronic acid 4mg IV (works in 2-4 days, lasts weeks). (4) Treat underlying cause. Dialysis if refractory</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="hypomag" class="condition-page">
    <div class="page-header"><h2>35. HYPOMAGNESEMIA</h2><div class="subtitle">Mg <1.5 mg/dL</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Causes:</strong> GI losses, diuretics, PPI, alcohol, DKA, refeeding syndrome</p>
        <p><strong>Symptoms:</strong> Tremor, tetany, weakness, arrhythmias. Often with concurrent hypokalemia/hypocalcemia (refractory until Mg corrected)</p>
        <p><strong>Treatment:</strong> Asymptomatic: Mag oxide 400mg PO BID-TID. Symptomatic/severe: Mag sulfate 1-2g IV over 15min (if torsades) or 4-6g IV over 3-6hr. Replete K+ and Ca+ simultaneously. Monitor DTRs (hypermagnesemia risk)</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="rhabdo" class="condition-page">
    <div class="page-header"><h2>36. RHABDOMYOLYSIS</h2><div class="subtitle">CK >1000 ‚Ä¢ Myoglobinuria ‚Ä¢ AKI Risk</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Causes:</strong> Trauma/crush injury, immobilization, seizures, strenuous exercise, statins, drugs (cocaine, PCP), heat stroke, neuroleptic malignant syndrome</p>
        <p><strong>Presentation:</strong> Muscle pain, weakness, dark urine (tea/cola-colored). Triad: myalgias, weakness, dark urine</p>
        <p><strong>Treatment:</strong> Aggressive IVF! NS 200-300 mL/hr (goal UOP >200 mL/hr) to flush myoglobin. Continue until CK downtrending and <5000. Monitor K+ closely (released from muscle), Ca+ (don't replte unless symptomatic/may worsen), phos. Dialysis if severe AKI/hyperkalemia. Avoid diuretics. Treat compartment syndrome if present</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="transfusion" class="condition-page">
    <div class="page-header"><h2>37. TRANSFUSION REACTIONS</h2><div class="subtitle">Acute Hemolytic ‚Ä¢ TRALI ‚Ä¢ TACO</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Acute Hemolytic (ABO incompatibility):</strong> Fever, chills, back/chest pain, hypotension within minutes. STOP transfusion immediately! IVF, pressors, urine alkalinization. Check direct Coombs, hemolysis labs</p>
        <p><strong>Febrile Non-Hemolytic:</strong> Most common. Temp >38¬∞C or 1¬∞C rise. Stop transfusion, check hemolysis labs. If negative, give acetaminophen, can resume slowly</p>
        <p><strong>TRALI:</strong> Acute resp distress within 6hr of transfusion. CXR shows bilateral infiltrates. Supportive care, may need intubation</p>
        <p><strong>TACO:</strong> Volume overload. JVD, HTN, pulmonary edema. Diurese</p>
        <p><strong>Allergic:</strong> Urticaria, pruritis. Stop, give antihistamine. Anaphylaxis: epi, steroids, aggressive support</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="pleural-effusion" class="condition-page">
    <div class="page-header"><h2>38. PLEURAL EFFUSION</h2><div class="subtitle">Transudate ‚Ä¢ Exudate</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Light's Criteria (Exudate if ‚â•1 present):</strong> (1) Pleural protein/serum protein >0.5, (2) Pleural LDH/serum LDH >0.6, (3) Pleural LDH >2/3 ULN serum LDH</p>
        <p><strong>Transudate causes:</strong> CHF (most common), cirrhosis, nephrotic syndrome, PE</p>
        <p><strong>Exudate causes:</strong> Pneumonia (parapneumonic), malignancy, TB, PE, pancreatitis</p>
        <p><strong>Treatment:</strong> Treat underlying cause. Therapeutic thoracentesis if symptomatic (dyspnea). Large bore chest tube if empyema. Send pleural fluid: pH, glucose, protein, LDH, cell count/diff, Gram stain/culture, cytology</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="pneumothorax" class="condition-page">
    <div class="page-header"><h2>39. PNEUMOTHORAX</h2><div class="subtitle">Spontaneous ‚Ä¢ Tension</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>Primary Spontaneous:</strong> Tall, thin young men. Smoking. Rupture of apical bleb</p>
        <p><strong>Secondary:</strong> Underlying lung disease (COPD, CF, PCP). Iatrogenic (central line, thoracentesis, mechanical ventilation)</p>
        <p><strong>Tension PTX:</strong> Hypotension, tracheal deviation, absent breath sounds, JVD. EMERGENCY! Needle decompression 2nd ICS midclavicular line immediately, then chest tube</p>
        <p><strong>Treatment:</strong> Small (<2cm, asymptomatic): Observation + supplemental O2. Large or symptomatic: Chest tube (pigtail 12-14Fr or 28-32Fr). Surgery if recurrent</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>

<div id="syncope" class="condition-page">
    <div class="page-header"><h2>40. SYNCOPE</h2><div class="subtitle">Vasovagal ‚Ä¢ Cardiac ‚Ä¢ Orthostatic</div></div>
    <div class="section"><div class="section-title">KEY POINTS</div><div class="section-content">
        <p><strong>High-Risk Features (San Francisco Syncope Rule):</strong> Abnormal ECG, hematocrit <30%, CHF history, dyspnea, SBP <90. If any present ‚Üí admit</p>
        <p><strong>Workup:</strong> History (prodrome, position, activity), ECG (every patient!), orthostatic vitals, consider echo/telemetry if cardiac suspected</p>
        <p><strong>Causes:</strong> Vasovagal (most common, benign), orthostatic hypotension, cardiac (arrhythmia, structural), neurologic (rare), medications</p>
        <p><strong>Treatment:</strong> Treat underlying cause. Vasovagal: reassurance, increase fluids/salt, avoid triggers, counterpressure maneuvers. Cardiac: cardiology referral. Orthostatic: increase fluids, compression stockings, adjust meds</p>
        <p><strong>Admit if:</strong> High-risk features, concerning ECG, cardiac cause suspected, recurrent with injury risk</p>
    </div></div>
    <a href="#toc" class="back-to-top">‚Üë Back to Table of Contents</a>
</div>
        <div class="footer-section">
            <p><strong>Internal Medicine Clinical Reference Guide</strong></p>
            <p>Evidence-based guidelines for hospital medicine</p>
            <p style="font-size: 8pt; margin-top: 15px;">Always consult institutional protocols and current literature. Updated 2025.</p>
        </div>
    </div>
    
    <script>
        // HEART Score Calculator
        function calculateHEART() {
            const history = parseInt(document.getElementById('heart-history').value);
            const ecg = parseInt(document.getElementById('heart-ecg').value);
            const age = parseInt(document.getElementById('heart-age').value);
            const risk = parseInt(document.getElementById('heart-risk').value);
            const trop = parseInt(document.getElementById('heart-trop').value);
            
            const score = history + ecg + age + risk + trop;
            
            let interpretation = '';
            let riskClass = '';
            
            if (score <= 3) {
                interpretation = `Score: ${score}/10 - LOW RISK (0.9-1.7% adverse cardiac events at 6 weeks). Consider outpatient workup.`;
                riskClass = '';
            } else if (score <= 6) {
                interpretation = `Score: ${score}/10 - MODERATE RISK (12-16% adverse cardiac events at 6 weeks). Admit for observation and further evaluation.`;
                riskClass = '';
            } else {
                interpretation = `Score: ${score}/10 - HIGH RISK (50-65% adverse cardiac events at 6 weeks). Admit for aggressive management, consider early invasive strategy.`;
                riskClass = 'high-risk';
            }
            
            document.getElementById('heart-result').innerHTML = `<div class="calc-result ${riskClass}">${interpretation}</div>`;
        }
        
        // TIMI STEMI Calculator
        function calculateTIMI_STEMI() {
            let score = 0;
            
            if (document.getElementById('timi-stemi-age65').checked) score += 2;
            if (document.getElementById('timi-stemi-age75').checked) score += 3;
            if (document.getElementById('timi-stemi-dm').checked) score += 1;
            if (document.getElementById('timi-stemi-bp').checked) score += 3;
            if (document.getElementById('timi-stemi-hr').checked) score += 2;
            if (document.getElementById('timi-stemi-killip').checked) score += 2;
            if (document.getElementById('timi-stemi-weight').checked) score += 1;
            if (document.getElementById('timi-stemi-anterior').checked) score += 1;
            if (document.getElementById('timi-stemi-time').checked) score += 1;
            
            let mortality = '';
            let riskClass = '';
            
            if (score === 0) {
                mortality = '0.8%';
            } else if (score === 1) {
                mortality = '1.6%';
            } else if (score === 2) {
                mortality = '2.2%';
            } else if (score === 3) {
                mortality = '4.4%';
            } else if (score === 4) {
                mortality = '7.3%';
            } else if (score === 5) {
                mortality = '12.4%';
            } else if (score === 6) {
                mortality = '16.1%';
            } else if (score === 7) {
                mortality = '23.4%';
            } else if (score === 8) {
                mortality = '26.8%';
            } else {
                mortality = '35.9%';
                riskClass = 'high-risk';
            }
            
            if (score > 6) riskClass = 'high-risk';
            
            const interpretation = `Score: ${score} - Predicted 30-day mortality: ${mortality}`;
            
            document.getElementById('timi-stemi-result').innerHTML = `<div class="calc-result ${riskClass}">${interpretation}</div>`;
        }
        
        // TIMI NSTEMI Calculator
        function calculateTIMI_NSTEMI() {
            let score = 0;
            
            if (document.getElementById('timi-nstemi-age').checked) score += 1;
            if (document.getElementById('timi-nstemi-risk').checked) score += 1;
            if (document.getElementById('timi-nstemi-cad').checked) score += 1;
            if (document.getElementById('timi-nstemi-asa').checked) score += 1;
            if (document.getElementById('timi-nstemi-angina').checked) score += 1;
            if (document.getElementById('timi-nstemi-ecg').checked) score += 1;
            if (document.getElementById('timi-nstemi-trop').checked) score += 1;
            
            let risk = '';
            let riskClass = '';
            
            if (score <= 2) {
                risk = '5% risk of death, MI, or urgent revascularization at 14 days - LOW RISK';
            } else if (score <= 4) {
                risk = '13% risk of death, MI, or urgent revascularization at 14 days - MODERATE RISK';
            } else {
                risk = '41% risk of death, MI, or urgent revascularization at 14 days - HIGH RISK. Consider early invasive strategy.';
                riskClass = 'high-risk';
            }
            
            const interpretation = `Score: ${score}/7 - ${risk}`;
            
            document.getElementById('timi-nstemi-result').innerHTML = `<div class="calc-result ${riskClass}">${interpretation}</div>`;
        }
        
        // GRACE Score Calculator
        function calculateGRACE() {
            const age = parseInt(document.getElementById('grace-age').value) || 0;
            const hr = parseInt(document.getElementById('grace-hr').value) || 0;
            const sbp = parseInt(document.getElementById('grace-sbp').value) || 0;
            const cr = parseFloat(document.getElementById('grace-cr').value) || 0;
            
            // Age points
            let agePoints = 0;
            if (age < 30) agePoints = 0;
            else if (age < 40) agePoints = 8;
            else if (age < 50) agePoints = 25;
            else if (age < 60) agePoints = 41;
            else if (age < 70) agePoints = 58;
            else if (age < 80) agePoints = 75;
            else agePoints = 91;
            
            // HR points
            let hrPoints = 0;
            if (hr < 50) hrPoints = 0;
            else if (hr < 70) hrPoints = 3;
            else if (hr < 90) hrPoints = 9;
            else if (hr < 110) hrPoints = 15;
            else if (hr < 150) hrPoints = 24;
            else if (hr < 200) hrPoints = 38;
            else hrPoints = 46;
            
            // SBP points
            let sbpPoints = 0;
            if (sbp < 80) sbpPoints = 58;
            else if (sbp < 100) sbpPoints = 53;
            else if (sbp < 120) sbpPoints = 43;
            else if (sbp < 140) sbpPoints = 34;
            else if (sbp < 160) sbpPoints = 24;
            else if (sbp < 200) sbpPoints = 10;
            else sbpPoints = 0;
            
            // Creatinine points
            let crPoints = 0;
            if (cr < 0.4) crPoints = 1;
            else if (cr < 0.8) crPoints = 4;
            else if (cr < 1.2) crPoints = 7;
            else if (cr < 1.6) crPoints = 10;
            else if (cr < 2.0) crPoints = 13;
            else if (cr < 4.0) crPoints = 21;
            else crPoints = 28;
            
            const arrest = document.getElementById('grace-arrest').checked ? 39 : 0;
            const st = document.getElementById('grace-st').checked ? 28 : 0;
            const enzymes = document.getElementById('grace-enzymes').checked ? 14 : 0;
            const killip = parseInt(document.getElementById('grace-killip').value);
            
            const score = agePoints + hrPoints + sbpPoints + crPoints + arrest + st + enzymes + killip;
            
            let risk = '';
            let riskClass = '';
            
            if (score < 109) {
                risk = 'LOW RISK - <1% in-hospital mortality, <3% 6-month mortality';
            } else if (score < 140) {
                risk = 'INTERMEDIATE RISK - 1-3% in-hospital mortality, 3-8% 6-month mortality';
            } else {
                risk = 'HIGH RISK - >3% in-hospital mortality, >8% 6-month mortality. Consider aggressive management.';
                riskClass = 'high-risk';
            }
            
            const interpretation = `GRACE Score: ${score} - ${risk}`;
            
            document.getElementById('grace-result').innerHTML = `<div class="calc-result ${riskClass}">${interpretation}</div>`;
        }
        
        // Wells Score for PE Calculator
        function calculateWells() {
            let score = 0;
            
            if (document.getElementById('wells-dvt').checked) score += 3;
            if (document.getElementById('wells-alt').checked) score += 3;
            if (document.getElementById('wells-hr').checked) score += 1.5;
            if (document.getElementById('wells-immob').checked) score += 1.5;
            if (document.getElementById('wells-prior').checked) score += 1.5;
            if (document.getElementById('wells-hemo').checked) score += 1;
            if (document.getElementById('wells-cancer').checked) score += 1;
            
            let interpretation = '';
            let riskClass = '';
            
            if (score <= 4) {
                interpretation = `Wells Score: ${score} - PE UNLIKELY. Consider D-dimer to rule out PE. If D-dimer negative, PE excluded.`;
            } else {
                interpretation = `Wells Score: ${score} - PE LIKELY. Proceed directly to CTPA or V/Q scan. Do not wait for D-dimer.`;
                riskClass = 'high-risk';
            }
            
            document.getElementById('wells-result').innerHTML = `<div class="calc-result ${riskClass}">${interpretation}</div>`;
        }
        
        // qSOFA Calculator
        function calculateQSOFA() {
            let score = 0;
            
            if (document.getElementById('qsofa-rr').checked) score += 1;
            if (document.getElementById('qsofa-ams').checked) score += 1;
            if (document.getElementById('qsofa-sbp').checked) score += 1;
            
            let interpretation = '';
            let riskClass = '';
            
            if (score < 2) {
                interpretation = `qSOFA Score: ${score}/3 - LOW RISK for poor outcomes. Does not exclude sepsis. Continue clinical assessment.`;
            } else {
                interpretation = `qSOFA Score: ${score}/3 - HIGH RISK for poor outcomes. Strongly consider sepsis. Calculate full SOFA score, obtain lactate, start sepsis bundle immediately.`;
                riskClass = 'high-risk';
            }
            
            document.getElementById('qsofa-result').innerHTML = `<div class="calc-result ${riskClass}">${interpretation}</div>`;
        }
        
        // FENa Calculator
        function calculateFENa() {
            const urineNa = parseFloat(document.getElementById('fena-urine-na').value);
            const serumNa = parseFloat(document.getElementById('fena-serum-na').value);
            const urineCr = parseFloat(document.getElementById('fena-urine-cr').value);
            const serumCr = parseFloat(document.getElementById('fena-serum-cr').value);
            
            if (!urineNa || !serumNa || !urineCr || !serumCr) {
                document.getElementById('fena-result').innerHTML = '<div class="calc-result">Please enter all values</div>';
                return;
            }
            
            // FENa = (Urine Na / Serum Na) / (Urine Cr / Serum Cr) √ó 100
            const fena = ((urineNa / serumNa) / (urineCr / serumCr)) * 100;
            
            let interpretation = '';
            let riskClass = '';
            
            if (fena < 1) {
                interpretation = `FENa: ${fena.toFixed(2)}% - Suggests PRERENAL AKI. Kidney is avidly retaining sodium (underperfused but functioning). Treat with fluids/optimize perfusion.`;
            } else if (fena <= 2) {
                interpretation = `FENa: ${fena.toFixed(2)}% - INDETERMINATE. Could be prerenal or early ATN. Consider clinical context and other findings.`;
                riskClass = '';
            } else {
                interpretation = `FENa: ${fena.toFixed(2)}% - Suggests INTRINSIC AKI (likely ATN). Kidney cannot conserve sodium (tubular damage). Supportive care, avoid nephrotoxins.`;
                riskClass = 'high-risk';
            }
            
            interpretation += '<br><br><strong>Note:</strong> FENa not valid if patient on diuretics. Use FEUrea instead (<35% = prerenal).';
            
            document.getElementById('fena-result').innerHTML = `<div class="calc-result ${riskClass}">${interpretation}</div>`;
        }
    </script>
</body>
</html>
